JPH0261474B2 - - Google Patents
Info
- Publication number
- JPH0261474B2 JPH0261474B2 JP57071660A JP7166082A JPH0261474B2 JP H0261474 B2 JPH0261474 B2 JP H0261474B2 JP 57071660 A JP57071660 A JP 57071660A JP 7166082 A JP7166082 A JP 7166082A JP H0261474 B2 JPH0261474 B2 JP H0261474B2
- Authority
- JP
- Japan
- Prior art keywords
- imidazole
- oxo
- dihydro
- methyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 claims abstract description 51
- 150000001412 amines Chemical class 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 5
- -1 dimethylphenyl Chemical group 0.000 claims description 44
- 239000001257 hydrogen Substances 0.000 claims description 22
- 229910052739 hydrogen Inorganic materials 0.000 claims description 22
- 125000000217 alkyl group Chemical group 0.000 claims description 19
- 125000004432 carbon atom Chemical group C* 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 150000002431 hydrogen Chemical group 0.000 claims description 14
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 10
- 229910052727 yttrium Inorganic materials 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 9
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 125000003944 tolyl group Chemical group 0.000 claims description 5
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical group 0.000 claims description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- NKWCGTOZTHZDHB-UHFFFAOYSA-N 1h-imidazol-1-ium-4-carboxylate Chemical compound OC(=O)C1=CNC=N1 NKWCGTOZTHZDHB-UHFFFAOYSA-N 0.000 claims description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 150000001735 carboxylic acids Chemical class 0.000 claims description 2
- 125000001589 carboacyl group Chemical group 0.000 claims 2
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 150000007529 inorganic bases Chemical class 0.000 claims 1
- XJSWLMGZMRUNLP-UHFFFAOYSA-N 2-oxo-1,3-dihydroimidazole-4-carboxylic acid Chemical class OC(=O)C1=CNC(=O)N1 XJSWLMGZMRUNLP-UHFFFAOYSA-N 0.000 abstract description 5
- MFAPRXKYGWLTNN-UHFFFAOYSA-N 5-(bromomethyl)-2-oxo-1,3-dihydroimidazole-4-carboxylic acid Chemical class OC(=O)C=1NC(=O)NC=1CBr MFAPRXKYGWLTNN-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003146 anticoagulant agent Substances 0.000 abstract description 2
- 229960004676 antithrombotic agent Drugs 0.000 abstract description 2
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 239000000496 cardiotonic agent Substances 0.000 abstract 1
- 230000003177 cardiotonic effect Effects 0.000 abstract 1
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 230000037396 body weight Effects 0.000 description 8
- 206010019280 Heart failures Diseases 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 5
- 238000007911 parenteral administration Methods 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- ZBNZAJFNDPPMDT-UHFFFAOYSA-N 1h-imidazole-5-carboxamide Chemical compound NC(=O)C1=CNC=N1 ZBNZAJFNDPPMDT-UHFFFAOYSA-N 0.000 description 2
- UKYBHEPQCODSCP-UHFFFAOYSA-N 2-hydroxyimino-3-oxobutanamide Chemical class CC(=O)C(=NO)C(N)=O UKYBHEPQCODSCP-UHFFFAOYSA-N 0.000 description 2
- RRMINFSIXCUCNS-UHFFFAOYSA-N 2-oxobutanamide Chemical compound CCC(=O)C(N)=O RRMINFSIXCUCNS-UHFFFAOYSA-N 0.000 description 2
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 2
- UTBULQCHEUWJNV-UHFFFAOYSA-N 4-phenylpiperidine Chemical compound C1CNCCC1C1=CC=CC=C1 UTBULQCHEUWJNV-UHFFFAOYSA-N 0.000 description 2
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 2
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 208000007530 Essential hypertension Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- WZELXJBMMZFDDU-UHFFFAOYSA-N Imidazol-2-one Chemical class O=C1N=CC=N1 WZELXJBMMZFDDU-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- PPNNJZOJEMOYCO-UHFFFAOYSA-N ethyl 2-oxo-5-[(4-phenylpiperidin-1-yl)methyl]-1,3-dihydroimidazole-4-carboxylate Chemical compound N1C(=O)NC(CN2CCC(CC2)C=2C=CC=CC=2)=C1C(=O)OCC PPNNJZOJEMOYCO-UHFFFAOYSA-N 0.000 description 2
- CNIUYOLZVQXGAI-UHFFFAOYSA-N ethyl 5-methyl-2-oxo-1,3-dihydroimidazole-4-carboxylate Chemical compound CCOC(=O)C=1NC(=O)NC=1C CNIUYOLZVQXGAI-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000297 inotrophic effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
- BZCOSCNPHJNQBP-UPHRSURJSA-N (z)-2,3-dihydroxybut-2-enedioic acid Chemical compound OC(=O)C(\O)=C(\O)C(O)=O BZCOSCNPHJNQBP-UPHRSURJSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- PIIKWFAHJOXWBH-UHFFFAOYSA-N 1,3-diacetyl-2-oxoimidazole-4-carboxylic acid Chemical class CC(=O)N1C=C(C(O)=O)N(C(C)=O)C1=O PIIKWFAHJOXWBH-UHFFFAOYSA-N 0.000 description 1
- PGNWHOXKMWQTDA-UHFFFAOYSA-N 1,3-diacetyl-5-ethyl-2-oxo-n-phenylimidazole-4-carboxamide Chemical compound CC(=O)N1C(=O)N(C(C)=O)C(CC)=C1C(=O)NC1=CC=CC=C1 PGNWHOXKMWQTDA-UHFFFAOYSA-N 0.000 description 1
- LLRDKNVOXVJWPB-UHFFFAOYSA-N 1,3-diacetylimidazol-2-one Chemical compound CC(=O)N1C=CN(C(C)=O)C1=O LLRDKNVOXVJWPB-UHFFFAOYSA-N 0.000 description 1
- AICIYIDUYNFPRY-UHFFFAOYSA-N 1,3-dihydro-2H-imidazol-2-one Chemical compound O=C1NC=CN1 AICIYIDUYNFPRY-UHFFFAOYSA-N 0.000 description 1
- NMIZONYLXCOHEF-UHFFFAOYSA-N 1h-imidazole-2-carboxamide Chemical compound NC(=O)C1=NC=CN1 NMIZONYLXCOHEF-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- QYQDUVUNDRJVQS-UHFFFAOYSA-N 2-oxo-n-phenyl-5-[(4-phenylpiperidin-1-yl)methyl]-1,3-dihydroimidazole-4-carboxamide;hydrochloride Chemical compound Cl.N1C(=O)NC(CN2CCC(CC2)C=2C=CC=CC=2)=C1C(=O)NC1=CC=CC=C1 QYQDUVUNDRJVQS-UHFFFAOYSA-N 0.000 description 1
- MSVRGSUFKIKEQS-UHFFFAOYSA-N 2-oxo-n-phenyl-5-[1-(4-phenylpiperidin-1-yl)ethyl]-1,3-dihydroimidazole-4-carboxamide;hydrochloride Chemical compound Cl.N1C(=O)NC(C(=O)NC=2C=CC=CC=2)=C1C(C)N(CC1)CCC1C1=CC=CC=C1 MSVRGSUFKIKEQS-UHFFFAOYSA-N 0.000 description 1
- PKRSYEPBQPFNRB-UHFFFAOYSA-N 2-phenoxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1OC1=CC=CC=C1 PKRSYEPBQPFNRB-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- LZAYOZUFUAMFLD-UHFFFAOYSA-N 4-(4-chlorophenyl)-4-hydroxypiperidine Chemical compound C=1C=C(Cl)C=CC=1C1(O)CCNCC1 LZAYOZUFUAMFLD-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-PZFLKRBQSA-N 4-amino-3,5-ditritiobenzoic acid Chemical compound [3H]c1cc(cc([3H])c1N)C(O)=O ALYNCZNDIQEVRV-PZFLKRBQSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- MNYMDMOMYOWIKL-UHFFFAOYSA-N 5-(1-bromoethyl)-2-oxo-n-phenyl-1,3-dihydroimidazole-4-carboxamide Chemical compound N1C(=O)NC(C(=O)NC=2C=CC=CC=2)=C1C(Br)C MNYMDMOMYOWIKL-UHFFFAOYSA-N 0.000 description 1
- XWWBMYCYEXGIFA-UHFFFAOYSA-N 5-ethyl-2-oxo-n-phenyl-1,3-dihydroimidazole-4-carboxamide Chemical compound N1C(=O)NC(C(=O)NC=2C=CC=CC=2)=C1CC XWWBMYCYEXGIFA-UHFFFAOYSA-N 0.000 description 1
- ZVZHIHUNSYBHMD-UHFFFAOYSA-N 5-ethyl-n,n-dimethyl-2-oxo-1,3-dihydroimidazole-4-carboxamide Chemical compound CCC=1NC(=O)NC=1C(=O)N(C)C ZVZHIHUNSYBHMD-UHFFFAOYSA-N 0.000 description 1
- XRNQHTNLAOHXKC-UHFFFAOYSA-N 5-methyl-2-oxo-1,3-dihydroimidazole-4-carboxamide Chemical compound CC=1NC(=O)NC=1C(N)=O XRNQHTNLAOHXKC-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 206010003178 Arterial thrombosis Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- YZSJUQIFYHUSKU-UHFFFAOYSA-N ethanol;propane-1,2-diol Chemical compound CCO.CC(O)CO YZSJUQIFYHUSKU-UHFFFAOYSA-N 0.000 description 1
- GKZBFKNGJXYXOM-UHFFFAOYSA-N ethyl 1,3,5-trimethyl-2-oxoimidazole-4-carboxylate Chemical compound CCOC(=O)C1=C(C)N(C)C(=O)N1C GKZBFKNGJXYXOM-UHFFFAOYSA-N 0.000 description 1
- BMAOZTGIDKBSMS-UHFFFAOYSA-N ethyl 1,3-diacetyl-5-(bromomethyl)-2-oxoimidazole-4-carboxylate Chemical compound CCOC(=O)C1=C(CBr)N(C(C)=O)C(=O)N1C(C)=O BMAOZTGIDKBSMS-UHFFFAOYSA-N 0.000 description 1
- KKBOTVRMEQEHAR-UHFFFAOYSA-N ethyl 1,3-dibenzoyl-5-[[4-(4-chlorophenyl)piperidin-1-yl]methyl]-2-oxoimidazole-4-carboxylate Chemical compound C=1C=CC=CC=1C(=O)N1C(=O)N(C(=O)C=2C=CC=CC=2)C(C(=O)OCC)=C1CN(CC1)CCC1C1=CC=C(Cl)C=C1 KKBOTVRMEQEHAR-UHFFFAOYSA-N 0.000 description 1
- DMJHFAKYMDEMFP-UHFFFAOYSA-N ethyl 1,3-dimethyl-2-oxo-5-[(4-phenylpiperidin-1-yl)methyl]imidazole-4-carboxylate;hydrochloride Chemical compound Cl.CN1C(=O)N(C)C(C(=O)OCC)=C1CN1CCC(C=2C=CC=CC=2)CC1 DMJHFAKYMDEMFP-UHFFFAOYSA-N 0.000 description 1
- ZPWXNOKCBGDSKB-UHFFFAOYSA-N ethyl 1-[(5-ethoxycarbonyl-2-oxo-1,3-dihydroimidazol-4-yl)methyl]-4-phenylpiperidine-4-carboxylate;hydrochloride Chemical compound Cl.N1C(=O)NC(CN2CCC(CC2)(C(=O)OCC)C=2C=CC=CC=2)=C1C(=O)OCC ZPWXNOKCBGDSKB-UHFFFAOYSA-N 0.000 description 1
- VDIVMSGVBUKJIL-UHFFFAOYSA-N ethyl 2-oxo-5-[(4-phenyl-3,6-dihydro-2h-pyridin-1-yl)methyl]-1,3-dihydroimidazole-4-carboxylate;hydrochloride Chemical compound Cl.N1C(=O)NC(CN2CC=C(CC2)C=2C=CC=CC=2)=C1C(=O)OCC VDIVMSGVBUKJIL-UHFFFAOYSA-N 0.000 description 1
- UDRQTGNVDSWVGY-UHFFFAOYSA-N ethyl 2-oxo-5-[(4-phenylpiperidin-1-yl)methyl]-1,3-dihydroimidazole-4-carboxylate;hydrochloride Chemical compound Cl.N1C(=O)NC(CN2CCC(CC2)C=2C=CC=CC=2)=C1C(=O)OCC UDRQTGNVDSWVGY-UHFFFAOYSA-N 0.000 description 1
- ZMFBMPLQJPRZOQ-UHFFFAOYSA-N ethyl 3-acetyl-5-(bromomethyl)-2-oxo-1h-imidazole-4-carboxylate Chemical compound CCOC(=O)C1=C(CBr)NC(=O)N1C(C)=O ZMFBMPLQJPRZOQ-UHFFFAOYSA-N 0.000 description 1
- XTXOMJPDMDBDOI-UHFFFAOYSA-N ethyl 4-(4-chlorophenyl)-1-[(5-ethoxycarbonyl-2-oxo-1,3-dihydroimidazol-4-yl)methyl]piperidine-4-carboxylate;hydrochloride Chemical compound Cl.N1C(=O)NC(CN2CCC(CC2)(C(=O)OCC)C=2C=CC(Cl)=CC=2)=C1C(=O)OCC XTXOMJPDMDBDOI-UHFFFAOYSA-N 0.000 description 1
- GNQRIOQBFWGPBU-UHFFFAOYSA-N ethyl 5-[(4-acetyl-4-phenylpiperidin-1-yl)methyl]-2-oxo-1,3-dihydroimidazole-4-carboxylate;hydrochloride Chemical compound Cl.N1C(=O)NC(CN2CCC(CC2)(C(C)=O)C=2C=CC=CC=2)=C1C(=O)OCC GNQRIOQBFWGPBU-UHFFFAOYSA-N 0.000 description 1
- BFKWTMSHDPEDPQ-UHFFFAOYSA-N ethyl 5-[(4-cyano-4-phenylpiperidin-1-yl)methyl]-2-oxo-1,3-dihydroimidazole-4-carboxylate;hydrochloride Chemical compound Cl.N1C(=O)NC(CN2CCC(CC2)(C#N)C=2C=CC=CC=2)=C1C(=O)OCC BFKWTMSHDPEDPQ-UHFFFAOYSA-N 0.000 description 1
- MXXZLKHPXGPNPB-UHFFFAOYSA-N ethyl 5-[[4-(4-chlorophenyl)-3,6-dihydro-2h-pyridin-1-yl]methyl]-2-oxo-1,3-dihydroimidazole-4-carboxylate;hydrochloride Chemical compound Cl.N1C(=O)NC(CN2CC=C(CC2)C=2C=CC(Cl)=CC=2)=C1C(=O)OCC MXXZLKHPXGPNPB-UHFFFAOYSA-N 0.000 description 1
- LNLRFOPTLLVROK-UHFFFAOYSA-N ethyl 5-[[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]methyl]-2-oxo-1,3-dihydroimidazole-4-carboxylate;hydrochloride Chemical compound Cl.N1C(=O)NC(CN2CCC(O)(CC2)C=2C=CC(Cl)=CC=2)=C1C(=O)OCC LNLRFOPTLLVROK-UHFFFAOYSA-N 0.000 description 1
- IOSXDUPFJVPLIO-UHFFFAOYSA-N ethyl 5-[[4-(4-chlorophenyl)piperidin-1-yl]methyl]-1,3-diethyl-2-oxoimidazole-4-carboxylate Chemical compound CCN1C(=O)N(CC)C(C(=O)OCC)=C1CN1CCC(C=2C=CC(Cl)=CC=2)CC1 IOSXDUPFJVPLIO-UHFFFAOYSA-N 0.000 description 1
- IPKJCLMKYDCXKC-UHFFFAOYSA-N ethyl 5-[[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]methyl]-2-oxo-1,3-dihydroimidazole-4-carboxylate;hydrochloride Chemical compound Cl.N1C(=O)NC(CN2CCC(O)(CC2)C=2C=CC(C)=CC=2)=C1C(=O)OCC IPKJCLMKYDCXKC-UHFFFAOYSA-N 0.000 description 1
- HXTOODIQKMHSAR-UHFFFAOYSA-N ethyl 5-[[4-hydroxy-4-[3-(trifluoromethyl)phenyl]piperidin-1-yl]methyl]-2-oxo-1,3-dihydroimidazole-4-carboxylate;hydrochloride Chemical compound Cl.N1C(=O)NC(CN2CCC(O)(CC2)C=2C=C(C=CC=2)C(F)(F)F)=C1C(=O)OCC HXTOODIQKMHSAR-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- GJRALLZBVZSRFG-UHFFFAOYSA-N n,5-dimethyl-2-oxo-1,3-dihydroimidazole-4-carboxamide Chemical compound CNC(=O)C=1NC(=O)NC=1C GJRALLZBVZSRFG-UHFFFAOYSA-N 0.000 description 1
- PCYMHVSGXOWLIX-UHFFFAOYSA-N n,n-dimethyl-2-oxo-5-[(4-phenylpiperidin-1-yl)methyl]-1,3-dihydroimidazole-4-carboxamide;hydrochloride Chemical compound Cl.N1C(=O)NC(CN2CCC(CC2)C=2C=CC=CC=2)=C1C(=O)N(C)C PCYMHVSGXOWLIX-UHFFFAOYSA-N 0.000 description 1
- ATVUIAALFHLXJI-UHFFFAOYSA-N n,n-dimethyl-2-oxo-5-[1-(4-phenylpiperidin-1-yl)ethyl]-1,3-dihydroimidazole-4-carboxamide;hydrochloride Chemical compound Cl.N1C(=O)NC(C(=O)N(C)C)=C1C(C)N(CC1)CCC1C1=CC=CC=C1 ATVUIAALFHLXJI-UHFFFAOYSA-N 0.000 description 1
- UNERGFQHDMGQLY-UHFFFAOYSA-N n-(2,4-dimethylphenyl)-2-oxo-5-[(4-phenylpiperidin-1-yl)methyl]-1,3-dihydroimidazole-4-carboxamide;hydrochloride Chemical compound Cl.CC1=CC(C)=CC=C1NC(=O)C1=C(CN2CCC(CC2)C=2C=CC=CC=2)NC(=O)N1 UNERGFQHDMGQLY-UHFFFAOYSA-N 0.000 description 1
- HVCFMEDOUDTYDA-UHFFFAOYSA-N n-(4-methoxyphenyl)-2-oxo-5-[(4-phenylpiperidin-1-yl)methyl]-1,3-dihydroimidazole-4-carboxamide;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1NC(=O)C1=C(CN2CCC(CC2)C=2C=CC=CC=2)NC(=O)N1 HVCFMEDOUDTYDA-UHFFFAOYSA-N 0.000 description 1
- SWAJJKROCOJICG-UHFFFAOYSA-N n-(4-methoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC=C(NC(=O)CC(C)=O)C=C1 SWAJJKROCOJICG-UHFFFAOYSA-N 0.000 description 1
- MWZNZTOTYXAAMJ-UHFFFAOYSA-N n-(4-methylphenyl)-2-oxo-5-[(4-phenylpiperidin-1-yl)methyl]-1,3-dihydroimidazole-4-carboxamide;hydrochloride Chemical compound Cl.C1=CC(C)=CC=C1NC(=O)C1=C(CN2CCC(CC2)C=2C=CC=CC=2)NC(=O)N1 MWZNZTOTYXAAMJ-UHFFFAOYSA-N 0.000 description 1
- MKKUOQALCIOHEW-UHFFFAOYSA-N n-tert-butyl-2-oxo-5-[(4-phenylpiperidin-1-yl)methyl]-1,3-dihydroimidazole-4-carboxamide;hydrochloride Chemical compound Cl.N1C(=O)NC(CN2CCC(CC2)C=2C=CC=CC=2)=C1C(=O)NC(C)(C)C MKKUOQALCIOHEW-UHFFFAOYSA-N 0.000 description 1
- PFKRWPHZFBOCSX-UHFFFAOYSA-N n-tert-butyl-5-methyl-2-oxo-1,3-dihydroimidazole-4-carboxamide Chemical compound CC=1NC(=O)NC=1C(=O)NC(C)(C)C PFKRWPHZFBOCSX-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000009090 positive inotropic effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 206010038464 renal hypertension Diseases 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007892 solid unit dosage form Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ïŒâäœçœ®ã«ïŒïŒâããšãã«âïŒâãã
ãªãžãã«ïŒã¡ãã«çœ®æåºããã€ã€ãããŸãŒã«âïŒ
âã«ã«ãã³é žèªå°äœé¡ã«é¢ãããæŽã«è©³ããã¯ã
æ¬çºæã¯æ¬¡ã®äžè¬åŒ K0661 ããã€ååç©ã«é¢ãããåŒäžïŒ²ã¯æ°ŽçŽ ãïŒãïŒå
ã®ççŽ ååã®äœçŽã¢ã«ãã«ãïŒãïŒåã®ççŽ åå
ã®äœçŽã¢ã«ã«ãã€ã«ãåã¯ãã³ãŸã€ã«ã§ããã
R1ã¯ããããã·ãïŒãïŒåã®ççŽ ååã®äœçŽã¢
ã«ã³ãã·ãã¢ãããïŒäœçŽã¢ã«ãã«ïŒã¢ãããïŒäœ
çŽã¢ã«ãã«ïŒ2ã¢ããåã¯âNHR5ïŒããã§R5ã¯ã
ãšãã«ãã¡ãã«ããšãã«ããžã¡ãã«ããšãã«åã¯
ã¡ããã·ããšãã«ïŒã§ãããR2ã¯æ°ŽçŽ åã¯ïŒã
ïŒåã®ççŽ ååã®äœçŽã¢ã«ãã«ã§ãããã¯æ°Ž
çŽ ãããã²ã³ãã¡ãã«ãã¡ããã·åã³ããªãã«ãª
ãã¡ãã«ã§ãããã¯æ°ŽçŽ ãããããã·ãã·ã¢
ããã¢ã»ãã«åã¯ïŒC1ã4äœçŽã¢ã«ã³ãã·ïŒã«ã«ã
ãã«ã§ãããY1ã¯æ°ŽçŽ ã§ããããåã¯ïŒ¹ãšY1ã¯
äžç·ã«äºéçµåã圢æãããæ¬çºæã¯æŽã«ã¢ãã³
é¡ã®è£œè¬åŠçã«åå ¥ããããé žä»å å¡©é¡ãå å«ã
ãã
ãªãžãã«ïŒã¡ãã«çœ®æåºããã€ã€ãããŸãŒã«âïŒ
âã«ã«ãã³é žèªå°äœé¡ã«é¢ãããæŽã«è©³ããã¯ã
æ¬çºæã¯æ¬¡ã®äžè¬åŒ K0661 ããã€ååç©ã«é¢ãããåŒäžïŒ²ã¯æ°ŽçŽ ãïŒãïŒå
ã®ççŽ ååã®äœçŽã¢ã«ãã«ãïŒãïŒåã®ççŽ åå
ã®äœçŽã¢ã«ã«ãã€ã«ãåã¯ãã³ãŸã€ã«ã§ããã
R1ã¯ããããã·ãïŒãïŒåã®ççŽ ååã®äœçŽã¢
ã«ã³ãã·ãã¢ãããïŒäœçŽã¢ã«ãã«ïŒã¢ãããïŒäœ
çŽã¢ã«ãã«ïŒ2ã¢ããåã¯âNHR5ïŒããã§R5ã¯ã
ãšãã«ãã¡ãã«ããšãã«ããžã¡ãã«ããšãã«åã¯
ã¡ããã·ããšãã«ïŒã§ãããR2ã¯æ°ŽçŽ åã¯ïŒã
ïŒåã®ççŽ ååã®äœçŽã¢ã«ãã«ã§ãããã¯æ°Ž
çŽ ãããã²ã³ãã¡ãã«ãã¡ããã·åã³ããªãã«ãª
ãã¡ãã«ã§ãããã¯æ°ŽçŽ ãããããã·ãã·ã¢
ããã¢ã»ãã«åã¯ïŒC1ã4äœçŽã¢ã«ã³ãã·ïŒã«ã«ã
ãã«ã§ãããY1ã¯æ°ŽçŽ ã§ããããåã¯ïŒ¹ãšY1ã¯
äžç·ã«äºéçµåã圢æãããæ¬çºæã¯æŽã«ã¢ãã³
é¡ã®è£œè¬åŠçã«åå ¥ããããé žä»å å¡©é¡ãå å«ã
ãã
äžã«èšåãããäœçŽã¢ã«ãã«ã¯ãïŒãïŒåã®ç
çŽ ååãå«æããããã®ãããªäœçŽã¢ã«ãã«ã®äŸ
ã¯ã¡ãã«ããšãã«ããããã«ãã€ãœãããã«ãå
ã³ããã«ã§ãããäœçŽã¢ã«ã³ãã·åºã®äŸã¯ã¡ãã
ã·ããšããã·åã³ããããã·ã§ãããäžã«èšåã
ããäœçŽã¢ã«ã«ãã€ã«åºã¯ïŒãïŒåã®ççŽ ååã
å«æããã¢ã»ãã«ãããããªãã«åã³ãããªã«ã
äŸãšããŠããã
çŽ ååãå«æããããã®ãããªäœçŽã¢ã«ãã«ã®äŸ
ã¯ã¡ãã«ããšãã«ããããã«ãã€ãœãããã«ãå
ã³ããã«ã§ãããäœçŽã¢ã«ã³ãã·åºã®äŸã¯ã¡ãã
ã·ããšããã·åã³ããããã·ã§ãããäžã«èšåã
ããäœçŽã¢ã«ã«ãã€ã«åºã¯ïŒãïŒåã®ççŽ ååã
å«æããã¢ã»ãã«ãããããªãã«åã³ãããªã«ã
äŸãšããŠããã
æ¬çºæååç©é¡ã®è¬åŠçã«åå
¥ãããé
žä»å å¡©
é¡ã¯ãäŸãã°å¡©é žãèåæ°ŽçŽ é žãç¡«é žãçé žçã®
ãããªç¡æ©é žãšã®å¡©é¡ïŒé ¢é žãããããªã³é žãã°
ãªã³ãŒã«é žãä¹³é žããã«ãã³é žãããã³é žããã¯
ãé žããããŒã«é žããããé žãé ç³é žãããã
é žãã¢ã¹ã³ã«ãã³é žããã¬ã€ã³é žãããããã·ã
ã¬ã€ã³é žãšãžããããã·ãã¬ã€ã³é žãå®æ¯éŠé žã
ããšãã«é ¢é žãïŒâã¢ããå®æ¯éŠé žãïŒâããã
ãã·å®æ¯éŠé žãã¢ã³ãã©ãã«é žãæ¡ç®é žããµãªã
ã«é žãïŒâã¢ãããµãªãã«é žãïŒâããšããã·å®
æ¯éŠé žãïŒâã¢ã»ããã·å®æ¯éŠé žããã³ãã«é žç
ã®ãããªææ©ã«ã«ãã³é žé¡ãšã®å¡©é¡ïŒåã³ã¡ã¿ã³
ã¹ã«ãã³é žãšïœâãã«ãšã³ã¹ã«ãã³é žã®ãããªæ
æ©ã¹ã«ãã³é žé¡ãšã®å¡©é¡ã§ããã
é¡ã¯ãäŸãã°å¡©é žãèåæ°ŽçŽ é žãç¡«é žãçé žçã®
ãããªç¡æ©é žãšã®å¡©é¡ïŒé ¢é žãããããªã³é žãã°
ãªã³ãŒã«é žãä¹³é žããã«ãã³é žãããã³é žããã¯
ãé žããããŒã«é žããããé žãé ç³é žãããã
é žãã¢ã¹ã³ã«ãã³é žããã¬ã€ã³é žãããããã·ã
ã¬ã€ã³é žãšãžããããã·ãã¬ã€ã³é žãå®æ¯éŠé žã
ããšãã«é ¢é žãïŒâã¢ããå®æ¯éŠé žãïŒâããã
ãã·å®æ¯éŠé žãã¢ã³ãã©ãã«é žãæ¡ç®é žããµãªã
ã«é žãïŒâã¢ãããµãªãã«é žãïŒâããšããã·å®
æ¯éŠé žãïŒâã¢ã»ããã·å®æ¯éŠé žããã³ãã«é žç
ã®ãããªææ©ã«ã«ãã³é žé¡ãšã®å¡©é¡ïŒåã³ã¡ã¿ã³
ã¹ã«ãã³é žãšïœâãã«ãšã³ã¹ã«ãã³é žã®ãããªæ
æ©ã¹ã«ãã³é žé¡ãšã®å¡©é¡ã§ããã
æ¬çºæååç©é¡ã®ïŒ²ãæ°ŽçŽ ã®å Žåã¯ã次ã®ãã
ã«ååç©ã®å¹Ÿã€ãã®äºå€ç°æ§äœåãå¯èœã§ããã
ã«ååç©ã®å¹Ÿã€ãã®äºå€ç°æ§äœåãå¯èœã§ããã
K0662
åŒäžâNR3R4ã¯äžèšã®ããã«çœ®æãããªãžã³
ã§ãããçš®ã ã®åºã¯å ã«å®çŸ©ããããšããã§ã
ãããããã®äºå€ç°æ§äœã¯é žæ§ã§ããã匷塩åºãš
åå¿ãããšæ¬¡åŒã®è¬åŠçã«åå ¥ããããå¡©é¡ãç
ããã
ã§ãããçš®ã ã®åºã¯å ã«å®çŸ©ããããšããã§ã
ãããããã®äºå€ç°æ§äœã¯é žæ§ã§ããã匷塩åºãš
åå¿ãããšæ¬¡åŒã®è¬åŠçã«åå ¥ããããå¡©é¡ãç
ããã
K0663
K0664
åŒäžçš®ã
ã®åºã¯äžã«å®çŸ©ãããŠãããïŒã¯ãã
ãªãŠã åã¯ã«ãªãŠã ã®ãããªè£œè¬åŠçã«åå ¥ãã
ããã¢ã«ã«ãªéå±ã§ããããã®é瀺ãéããŠãçš
èªïŒâãªããœâ1Hâã€ãããŸãŒã«ã¯äžã«è¿°ã¹ã
äºå€ç°æ§äœé¡åã¯äºå€ç°æ§äœã®å¡©é¡ã®ä»»æã®ãã®
ãæå³ããã
ãªãŠã åã¯ã«ãªãŠã ã®ãããªè£œè¬åŠçã«åå ¥ãã
ããã¢ã«ã«ãªéå±ã§ããããã®é瀺ãéããŠãçš
èªïŒâãªããœâ1Hâã€ãããŸãŒã«ã¯äžã«è¿°ã¹ã
äºå€ç°æ§äœé¡åã¯äºå€ç°æ§äœã®å¡©é¡ã®ä»»æã®ãã®
ãæå³ããã
æ¬çºæååç©ã®äŸãšããŠã次ã®ãã®ãããã
ïŒâããïŒâïŒïŒâã¯ããããšãã«ïŒâïŒâãããª
ãžãã«ãâã¡ãã«ãâïŒïŒïŒâãžãããâïŒâãªã
ãœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã âãšãã«âïŒâããïŒâïŒïŒâã¡ãã«ããšãã«ïŒ
âïŒâãããªãžãã«ãã¡ãã«ãâïŒïŒïŒâãžãã
ãâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«
ãããµãã ãšãã«ïŒâããïŒâïŒïŒâãã«ãªãããšãã«ïŒâïŒ
âãããªãžãã«ãã¡ãã«ãâïŒïŒïŒâãžãããâ
ïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãã
ã·ã¬ãŒã ãšãã«ïŒâããïŒâïŒïŒâããã¢ããšãã«ïŒâïŒâ
ãããªãžãã«ãã¡ãã«ãâïŒïŒïŒâãžãããâïŒ
âãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·
ã¬ãŒã ïŒâããïŒâïŒïŒâã¡ãã«ããšãã«ïŒâïŒâãããª
ãžãã«ãã¡ãã«ãâïŒïŒïŒâãžãããââããš
ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«
ã«ãããµãã ïŒâãïŒïŒâããšãã«âïŒâã¡ããã·ã«ã«ããã«
âïŒâãããªãžãã«ïŒã¡ãã«ãââã¡ãã«ããš
ãã«ïŒâïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€
ãããŸãŒã«âïŒâã«ã«ãããµããâãšãã«ïŒïŒïŒ
âãžãããâïŒâãïŒâãïŒâïŒïŒâã¡ãã«ããšã
ã«ïŒâïŒâãããªãžãã«ããšãã«ãâïŒâãªããœâ
1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒã ãšãã«ïŒïŒïŒâãžãããâïŒâãïŒïŒâããšãã«
âïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒâããªãžã
ã«ïŒã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«â
ïŒâã«ã«ããã·ã¬ãŒã ãšãã«ïŒâãïŒïŒâããããã·âïŒâããšãã«â
ïŒâãããªãžãã«ïŒã¡ãã«ãâïŒïŒïŒâãžããã
âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ã
ãã·ã¬ãŒã ã¡ãã«ïŒïŒïŒâãžããããªãã«âïŒïŒïŒâãžã
ããâïŒâããïŒâã¯ããããšãã«ïŒâïŒâãããª
ãžãã«ãã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒ
ã«âïŒâã«ã«ããã·ã¬ãŒã ãšãã«ïŒïŒïŒâãžãã³ãŸã€ã«âïŒïŒïŒâãžãã
ãâïŒâããïŒâïŒïŒâã¯ããããšãã«ïŒâïŒâãã
ãªãžãã«ãã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸ
ãŒã«âïŒâã«ã«ããã·ã¬ãŒã ãšãã«ïŒïŒïŒâãžãããâïŒïŒïŒâãžãšãã«â
ïŒâããïŒâïŒïŒâã¯ããããšãã«ïŒâïŒâãããªãž
ãã«ãã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ããã·ã¬ãŒã æ¬çºæååç©é¡ã¯ã åŒ K0665 ãåŒäžïŒºã¯æ°ŽçŽ ãã®ååç©ã®ãããªïŒïŒïŒâãžã¢
ã»ãã«ã€ãããŸãã³ã®èçŽ åã«ãã€ãŠã€ãããã
ãBrã®å Žåã®ååç©ãçãããåå¿ã¯éé žå
ãã³ãŸã€ã«ã®ãããªéé¢åºéå§å€ã®ååšäžã«åå¡©
åççŽ ã®ãããªé©åœãªæº¶åªäžã§ïŒ®âããã¢ãµã¯ã·
ã³ã€ããã䜿çšããŠè¡ãªããããç¹å®çãªãžã¢ã»
ãã«åºçºææã¯ã察å¿ããïŒïŒïŒâæªçœ®æã€ãã
ãŸãã³ãããå¡©åã¢ã»ãã«åã¯ç¡æ°Žé ¢é žã§ã®ã¢ã»
ãã«åã«ãã€ãŠåŸããããR1ãã¢ã«ã³ãã·ã®æ
ã«ã¯ãåºçºãšã¹ãã«ã¯ããããã³ã¹ããŒ
ïŒDuschinskyïŒåã³ãã©ã³ïŒDolanïŒãJ.Am.
Chem.Soc.68å·»2350é ïŒ1946幎ïŒã«èšèŒã®æé ã«
ãã€ãŠåŸããããR1ãã¢ããåºãå«æããæã¯ã
ã€ãããŸãŒã«âïŒâã«ã«ãããµããã¯é©åœãªïŒ®â
眮æïŒâïŒããããã·ã€ããïŒâïŒâãªããœâãã¿
ã³ã¢ããããåŸãããããã¯é¢äžããã¢ããã«å¿
ããŠæ¥è§Šçã«ãåã¯ååŠçã«ã察å¿ããïŒâã¢ã
ãååç©ãžéå ããããçããïŒâã¢ããååç©
ã次ã«ã·ã¢ã³åã«ãªãŠã ãšåå¿ããããšãã€ãã
ãŸãŒã«ã«ã«ãããµãããçããã
ãžãã«ãâã¡ãã«ãâïŒïŒïŒâãžãããâïŒâãªã
ãœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã âãšãã«âïŒâããïŒâïŒïŒâã¡ãã«ããšãã«ïŒ
âïŒâãããªãžãã«ãã¡ãã«ãâïŒïŒïŒâãžãã
ãâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«
ãããµãã ãšãã«ïŒâããïŒâïŒïŒâãã«ãªãããšãã«ïŒâïŒ
âãããªãžãã«ãã¡ãã«ãâïŒïŒïŒâãžãããâ
ïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãã
ã·ã¬ãŒã ãšãã«ïŒâããïŒâïŒïŒâããã¢ããšãã«ïŒâïŒâ
ãããªãžãã«ãã¡ãã«ãâïŒïŒïŒâãžãããâïŒ
âãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·
ã¬ãŒã ïŒâããïŒâïŒïŒâã¡ãã«ããšãã«ïŒâïŒâãããª
ãžãã«ãã¡ãã«ãâïŒïŒïŒâãžãããââããš
ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«
ã«ãããµãã ïŒâãïŒïŒâããšãã«âïŒâã¡ããã·ã«ã«ããã«
âïŒâãããªãžãã«ïŒã¡ãã«ãââã¡ãã«ããš
ãã«ïŒâïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€
ãããŸãŒã«âïŒâã«ã«ãããµããâãšãã«ïŒïŒïŒ
âãžãããâïŒâãïŒâãïŒâïŒïŒâã¡ãã«ããšã
ã«ïŒâïŒâãããªãžãã«ããšãã«ãâïŒâãªããœâ
1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒã ãšãã«ïŒïŒïŒâãžãããâïŒâãïŒïŒâããšãã«
âïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒâããªãžã
ã«ïŒã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«â
ïŒâã«ã«ããã·ã¬ãŒã ãšãã«ïŒâãïŒïŒâããããã·âïŒâããšãã«â
ïŒâãããªãžãã«ïŒã¡ãã«ãâïŒïŒïŒâãžããã
âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ã
ãã·ã¬ãŒã ã¡ãã«ïŒïŒïŒâãžããããªãã«âïŒïŒïŒâãžã
ããâïŒâããïŒâã¯ããããšãã«ïŒâïŒâãããª
ãžãã«ãã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒ
ã«âïŒâã«ã«ããã·ã¬ãŒã ãšãã«ïŒïŒïŒâãžãã³ãŸã€ã«âïŒïŒïŒâãžãã
ãâïŒâããïŒâïŒïŒâã¯ããããšãã«ïŒâïŒâãã
ãªãžãã«ãã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸ
ãŒã«âïŒâã«ã«ããã·ã¬ãŒã ãšãã«ïŒïŒïŒâãžãããâïŒïŒïŒâãžãšãã«â
ïŒâããïŒâïŒïŒâã¯ããããšãã«ïŒâïŒâãããªãž
ãã«ãã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ããã·ã¬ãŒã æ¬çºæååç©é¡ã¯ã åŒ K0665 ãåŒäžïŒºã¯æ°ŽçŽ ãã®ååç©ã®ãããªïŒïŒïŒâãžã¢
ã»ãã«ã€ãããŸãã³ã®èçŽ åã«ãã€ãŠã€ãããã
ãBrã®å Žåã®ååç©ãçãããåå¿ã¯éé žå
ãã³ãŸã€ã«ã®ãããªéé¢åºéå§å€ã®ååšäžã«åå¡©
åççŽ ã®ãããªé©åœãªæº¶åªäžã§ïŒ®âããã¢ãµã¯ã·
ã³ã€ããã䜿çšããŠè¡ãªããããç¹å®çãªãžã¢ã»
ãã«åºçºææã¯ã察å¿ããïŒïŒïŒâæªçœ®æã€ãã
ãŸãã³ãããå¡©åã¢ã»ãã«åã¯ç¡æ°Žé ¢é žã§ã®ã¢ã»
ãã«åã«ãã€ãŠåŸããããR1ãã¢ã«ã³ãã·ã®æ
ã«ã¯ãåºçºãšã¹ãã«ã¯ããããã³ã¹ããŒ
ïŒDuschinskyïŒåã³ãã©ã³ïŒDolanïŒãJ.Am.
Chem.Soc.68å·»2350é ïŒ1946幎ïŒã«èšèŒã®æé ã«
ãã€ãŠåŸããããR1ãã¢ããåºãå«æããæã¯ã
ã€ãããŸãŒã«âïŒâã«ã«ãããµããã¯é©åœãªïŒ®â
眮æïŒâïŒããããã·ã€ããïŒâïŒâãªããœâãã¿
ã³ã¢ããããåŸãããããã¯é¢äžããã¢ããã«å¿
ããŠæ¥è§Šçã«ãåã¯ååŠçã«ã察å¿ããïŒâã¢ã
ãååç©ãžéå ããããçããïŒâã¢ããååç©
ã次ã«ã·ã¢ã³åã«ãªãŠã ãšåå¿ããããšãã€ãã
ãŸãŒã«ã«ã«ãããµãããçããã
äžã§åŸãããããã¢ååç©ã¯ãâã¢ã»ãã«åº
ã®äžæ¹åã¯åæ¹ãé€ãããã«é ¢é žäžã®èçŽ æ°ŽçŽ é ž
ã§åŠçåºæ¥ãã次ã«åºããã€ãããŸãã³ã åŒ K0666 ãåŒäžïŒžãåã³Y1ã¯äžã§å®çŸ©ããããšããã
ã®é©åœãªã¢ãã³ã§åŠçãããšãæ¬çºæã®ææã®å
åç©ãçããã
ã®äžæ¹åã¯åæ¹ãé€ãããã«é ¢é žäžã®èçŽ æ°ŽçŽ é ž
ã§åŠçåºæ¥ãã次ã«åºããã€ãããŸãã³ã åŒ K0666 ãåŒäžïŒžãåã³Y1ã¯äžã§å®çŸ©ããããšããã
ã®é©åœãªã¢ãã³ã§åŠçãããšãæ¬çºæã®ææã®å
åç©ãçããã
æ¬æ¹æ³ã¯ïŒïŒïŒâæªçœ®æã€ãããŸãã³é¡ã䜿çš
ããŠèšèŒããããã察å¿ããïŒïŒïŒâãžã¢ã»ãã«
ååç©åã¯åæ§ã«çœ®æãããååç©é¡ã䜿çšãã
ããšãå¯èœã§ãããããã®ãããªååç©ã䜿çšã
ãæã¯ãã¢ãã³ãã¢ã·ã«åºãšãåå¿ããŠãè±ã¢ã»
ãã«åããã€ãããŸãã³åã³ïŒ®âã¢ã·ã«ã¢ãã³ã
çãããåŸã€ãŠãã®åå¿ãè¡ãåŸãããã«ããã
ãã«ã¢ãã³ã®éå°éã䜿çšããå¿ èŠããããã䜿
çšã®ã¢ãã³ã容æã«å ¥æã§ãããå®äŸ¡ã§ãªãæ
ã¯ãæãŸããæ¹æ³ã§ã¯ãªãã
ããŠèšèŒããããã察å¿ããïŒïŒïŒâãžã¢ã»ãã«
ååç©åã¯åæ§ã«çœ®æãããååç©é¡ã䜿çšãã
ããšãå¯èœã§ãããããã®ãããªååç©ã䜿çšã
ãæã¯ãã¢ãã³ãã¢ã·ã«åºãšãåå¿ããŠãè±ã¢ã»
ãã«åããã€ãããŸãã³åã³ïŒ®âã¢ã·ã«ã¢ãã³ã
çãããåŸã€ãŠãã®åå¿ãè¡ãåŸãããã«ããã
ãã«ã¢ãã³ã®éå°éã䜿çšããå¿ èŠããããã䜿
çšã®ã¢ãã³ã容æã«å ¥æã§ãããå®äŸ¡ã§ãªãæ
ã¯ãæãŸããæ¹æ³ã§ã¯ãªãã
ãäœçŽã¢ã«ã«ãã€ã«åã¯ãã³ãŸã€ã«ãè¡šãã
å Žåã®ååç©ã¯ããæ°ŽçŽ ãè¡šããå Žåã®ååç©
ãšéå°éã®é©åœãªé žç¡æ°Žç©åã¯é žå¡©åç©ãšã®åå¿
ã«ãã€ãŠåŸãããã
å Žåã®ååç©ã¯ããæ°ŽçŽ ãè¡šããå Žåã®ååç©
ãšéå°éã®é©åœãªé žç¡æ°Žç©åã¯é žå¡©åç©ãšã®åå¿
ã«ãã€ãŠåŸãããã
æ¬çºæååç©é¡ã¯ããã€è¡æ§å¿äžå
šãåéšå¿äž
å šãåŸéšå¿äžå šãå·Šå¿å®€å¿äžå šãåã¯å³å¿å®€å¿äž
å šãå«ããå¿äžå šã®åŠçœ®ãåã¯åŒ·å¿å€ã«ããå¿è
äœçšã®åŒ·åãå¿ èŠãšãããã®ä»ã®çç¶ã®åŠçœ®ã«äœ¿
çšã§ãããå€ãã®ç¹ã§ãããã®ååç©ã¯ãžã®ã¿ãª
ã¹ç¶ã®äœçšããã€ãŠãããæ¬çºæååç©é¡ã¯ãäž
次åã¯æ¬æ æ§é«è¡å§ããã«ã¢ã³ã§èªå°ãããé«è¡
å§ãè æ§é«è¡å§ãåã³ååŠçã«èªå°ãããé«è¡å§
ãå«ããé«è¡å§ã®åŠçœ®ã«ã䜿çšã§ãããæåŸã«æ¬
çºæååç©é¡ã¯ãæè¡æ å€ãšããŠã䜿çšã§ããã
ãããã¯è¡å°æ¿éåãé²ãããšã«ãã€ãŠè¡æ¶²ååº
ã«åœ±é¿ãäžãããè¡å°æ¿ã¯åæçç¶ã§ãéå¡æ®µé
ã«ãããŠãè¡æ çç¶ã§æåãªåœ¹å²ãæãããŠã
ããåèè¡æ çãç¹ã«å¿çãšè³ã«è¡æ¶²ãäŸçµŠãã
åèã¯ãæ»äº¡ãšå»çŸã®äž»å°çãªåå ã§ããã
å šãåŸéšå¿äžå šãå·Šå¿å®€å¿äžå šãåã¯å³å¿å®€å¿äž
å šãå«ããå¿äžå šã®åŠçœ®ãåã¯åŒ·å¿å€ã«ããå¿è
äœçšã®åŒ·åãå¿ èŠãšãããã®ä»ã®çç¶ã®åŠçœ®ã«äœ¿
çšã§ãããå€ãã®ç¹ã§ãããã®ååç©ã¯ãžã®ã¿ãª
ã¹ç¶ã®äœçšããã€ãŠãããæ¬çºæååç©é¡ã¯ãäž
次åã¯æ¬æ æ§é«è¡å§ããã«ã¢ã³ã§èªå°ãããé«è¡
å§ãè æ§é«è¡å§ãåã³ååŠçã«èªå°ãããé«è¡å§
ãå«ããé«è¡å§ã®åŠçœ®ã«ã䜿çšã§ãããæåŸã«æ¬
çºæååç©é¡ã¯ãæè¡æ å€ãšããŠã䜿çšã§ããã
ãããã¯è¡å°æ¿éåãé²ãããšã«ãã€ãŠè¡æ¶²ååº
ã«åœ±é¿ãäžãããè¡å°æ¿ã¯åæçç¶ã§ãéå¡æ®µé
ã«ãããŠãè¡æ çç¶ã§æåãªåœ¹å²ãæãããŠã
ããåèè¡æ çãç¹ã«å¿çãšè³ã«è¡æ¶²ãäŸçµŠãã
åèã¯ãæ»äº¡ãšå»çŸã®äž»å°çãªåå ã§ããã
æ¬ååç©é¡ã®æé«è¡å§äœçšã¯èªç¶çé«è¡å§ã®ã©
ãã12å¹ã®çŸ€ã䜿çšããŠç«èšŒããããã©ããã®å°Ÿ
ã®åºéšåšå²ã®å§åã«ããªã¯ã«ãŒããŒ
ïŒpressurecuff occluderïŒã«ãã€ãŠè¡å§ã枬å®ã
ããåç©ã®è¡å§æž¬å®ãè¡ãªãã賊圢å€äžã®è©Šéšå
åç©ã50mgïŒKgã®æäžéã§çµå£æäžããè©Šéšåå
ç©ã®æäžåŸïŒãïŒãïŒãïŒåã³24æéã«åã³è¡å§
ã枬å®ããã芳å¯ãããè¡å§ã®å·®ãåæããçµ±èš
çã«ææãã©ããã確å®ãããè©Šéšååç©ã®æäž
ã«äœ¿ããã賊圢å€ã¯ãåç¬äœ¿çšæã«è¡å§ã«èãã
圱é¿ãäžããªãã€ãã
ãã12å¹ã®çŸ€ã䜿çšããŠç«èšŒããããã©ããã®å°Ÿ
ã®åºéšåšå²ã®å§åã«ããªã¯ã«ãŒããŒ
ïŒpressurecuff occluderïŒã«ãã€ãŠè¡å§ã枬å®ã
ããåç©ã®è¡å§æž¬å®ãè¡ãªãã賊圢å€äžã®è©Šéšå
åç©ã50mgïŒKgã®æäžéã§çµå£æäžããè©Šéšåå
ç©ã®æäžåŸïŒãïŒãïŒãïŒåã³24æéã«åã³è¡å§
ã枬å®ããã芳å¯ãããè¡å§ã®å·®ãåæããçµ±èš
çã«ææãã©ããã確å®ãããè©Šéšååç©ã®æäž
ã«äœ¿ããã賊圢å€ã¯ãåç¬äœ¿çšæã«è¡å§ã«èãã
圱é¿ãäžããªãã€ãã
æ¬ååç©é¡ã®åŒ·å¿äœçšã¯æ¬¡ã®æé ã«ãã€ãŠäŸèšŒ
ãããããŠãªãŒã«ãã³ã»ãããã€ãŒã²ãã¿ã²ãŒãž
ã¢ãŒãã麻é ãã¿ã®ç¬ã®å¿èã«å€ç§çã«ç§»æ€ãã
å¿èåçž®åã枬å®ãããåç©ã®çããŠãã城åã
10åéå®å®ã§ãã€ãåŸãè©Šéšååç©ã®éèå æäž
ã0.3mgïŒKgã®æäžéã§éå§ããå¹æãèŠããªã
å Žåã¯ïŒãïŒåã³10mgïŒKgãšæäžéãé«ããŠç¶ã
ããæ¬çºæååç©é¡ã®ãããªæŽ»æ§ååç©ã¯ããã®
æ¹æ³ã§æž¬å®ãããå¿èåçž®åãé«ããçã®éœæ§ã®
å€åå¹æãæã¯åŒ·å¿å¹æãçºæ®ããã
ãããããŠãªãŒã«ãã³ã»ãããã€ãŒã²ãã¿ã²ãŒãž
ã¢ãŒãã麻é ãã¿ã®ç¬ã®å¿èã«å€ç§çã«ç§»æ€ãã
å¿èåçž®åã枬å®ãããåç©ã®çããŠãã城åã
10åéå®å®ã§ãã€ãåŸãè©Šéšååç©ã®éèå æäž
ã0.3mgïŒKgã®æäžéã§éå§ããå¹æãèŠããªã
å Žåã¯ïŒãïŒåã³10mgïŒKgãšæäžéãé«ããŠç¶ã
ããæ¬çºæååç©é¡ã®ãããªæŽ»æ§ååç©ã¯ããã®
æ¹æ³ã§æž¬å®ãããå¿èåçž®åãé«ããçã®éœæ§ã®
å€åå¹æãæã¯åŒ·å¿å¹æãçºæ®ããã
æ¬çºæååç©é¡ã®æè¡æ äœçšã¯æ¬¡ã®æé ã§ç«èšŒ
ãããããããé žãå ããè¡å°æ¿ã®è±å¯ãªããã®
è¡æŒ¿ã«ã¢ããã·ã³äºçé žãå ãããšãè¡å°æ¿ã®å ž
åçãªéåãèµ·ããæè¡æ äœçšã¯ããããé žåã
ããè¡å°æ¿ã®è±å¯ãªããã®è¡æŒ¿ã«ãè©Šéšååç©ã
ïŒã10ã30åã³100ÎŒgïŒmlã®æ¿åºŠã§å ããç¶ããŠ
ã¢ããã·ã³äºçé žãå ããè¡å°æ¿éåã®é»å®³çšåºŠ
ã芳å¯ããã
ãããããããé žãå ããè¡å°æ¿ã®è±å¯ãªããã®
è¡æŒ¿ã«ã¢ããã·ã³äºçé žãå ãããšãè¡å°æ¿ã®å ž
åçãªéåãèµ·ããæè¡æ äœçšã¯ããããé žåã
ããè¡å°æ¿ã®è±å¯ãªããã®è¡æŒ¿ã«ãè©Šéšååç©ã
ïŒã10ã30åã³100ÎŒgïŒmlã®æ¿åºŠã§å ããç¶ããŠ
ã¢ããã·ã³äºçé žãå ããè¡å°æ¿éåã®é»å®³çšåºŠ
ã芳å¯ããã
æãã§ããå¹æãéæããããã«çš®ã
ã®æ¹æ³ã§
ååç©ãæäžã§ãããååç©ãåç¬ã§ãã補è¬åŠ
調補å€ã®åœ¢ã§ã§ããåŠçœ®ããããšããæ£è ã«çµå£
åã¯éçµå£çã«ãããªãã¡éèå åã¯çèå ã«æ
äžã§ãããååç©ã®æäžéã¯é«è¡å§ãå¿äžå šåã¯
è¡æ ã®çšåºŠåã³æäžæ¹æ³ã«ãã€ãŠå€ãããçµå£æ
äžã«ã¯ãååç©ã®æé«è¡å§æå¹éã¯ãïŒæ¥åœãæ£
è ã®äœéKgåœãçŽ0.1mgãªããçŽ50mgã奜ãŸãã
ã¯ïŒæ¥åœãæ£è ã®äœéKgåœãçŽïŒmgãªããçŽ30mg
ã§ããã
ååç©ãæäžã§ãããååç©ãåç¬ã§ãã補è¬åŠ
調補å€ã®åœ¢ã§ã§ããåŠçœ®ããããšããæ£è ã«çµå£
åã¯éçµå£çã«ãããªãã¡éèå åã¯çèå ã«æ
äžã§ãããååç©ã®æäžéã¯é«è¡å§ãå¿äžå šåã¯
è¡æ ã®çšåºŠåã³æäžæ¹æ³ã«ãã€ãŠå€ãããçµå£æ
äžã«ã¯ãååç©ã®æé«è¡å§æå¹éã¯ãïŒæ¥åœãæ£
è ã®äœéKgåœãçŽ0.1mgãªããçŽ50mgã奜ãŸãã
ã¯ïŒæ¥åœãæ£è ã®äœéKgåœãçŽïŒmgãªããçŽ30mg
ã§ããã
éçµå£æäžã«ã¯ãååç©ã®æé«è¡å§æå¹éã¯ã
ïŒæ¥åœãæ£è ã®äœéKgåœãçŽ0.01mgãªããçŽ50
mgã奜ãŸããã¯ïŒæ¥åœãæ£è ã®äœéKgåœãçŽ0.1
mgãªããçŽ20.0mgãŸã§ã§ãããçµå£åã¯éçµå£æ
äžã«ã¯ãååç©ã®åŒ·å¿æå¹éã¯ïŒæ¥åœãæ£è ã®äœ
éKgåœãçŽ0.1mgãªããçŽ50mgãŸã§ã奜ãŸããã¯
ïŒæ¥åœãæ£è ã®äœéKgåœãçŽ0.1mgãªããçŽ20.0
mgã§ãããçµå£åã¯éçµå£æäžã«ã¯ãååç©ã®æ
åéæå¹éã¯ïŒæ¥åœãæ£è ã®äœéKgåœãçŽ0.1mg
ãªããçŽ100mgãŸã§ã奜ãŸããã¯ïŒæ¥åœãæ£è ã®
äœéKgåœãçŽ0.1mgãªããçŽ50mgã§ããã
ïŒæ¥åœãæ£è ã®äœéKgåœãçŽ0.01mgãªããçŽ50
mgã奜ãŸããã¯ïŒæ¥åœãæ£è ã®äœéKgåœãçŽ0.1
mgãªããçŽ20.0mgãŸã§ã§ãããçµå£åã¯éçµå£æ
äžã«ã¯ãååç©ã®åŒ·å¿æå¹éã¯ïŒæ¥åœãæ£è ã®äœ
éKgåœãçŽ0.1mgãªããçŽ50mgãŸã§ã奜ãŸããã¯
ïŒæ¥åœãæ£è ã®äœéKgåœãçŽ0.1mgãªããçŽ20.0
mgã§ãããçµå£åã¯éçµå£æäžã«ã¯ãååç©ã®æ
åéæå¹éã¯ïŒæ¥åœãæ£è ã®äœéKgåœãçŽ0.1mg
ãªããçŽ100mgãŸã§ã奜ãŸããã¯ïŒæ¥åœãæ£è ã®
äœéKgåœãçŽ0.1mgãªããçŽ50mgã§ããã
çµå£æäžã«ã¯ãåäœé©éã¯äŸãã°æŽ»æ§æåïŒã
100mgãå«æãããéçµå£æäžã«ã¯ãåäœé©éã¯
掻æ§æåã0.5ãªãã50mgãå«æãããååç©ã
æ¯æ¥ããè¿ãæäžããã®ã奜ãŸãããæäžéã¯æ£
è ã®çç¶ãšæäžæ¹æ³ã«ãã€ãŠå€ããã
100mgãå«æãããéçµå£æäžã«ã¯ãåäœé©éã¯
掻æ§æåã0.5ãªãã50mgãå«æãããååç©ã
æ¯æ¥ããè¿ãæäžããã®ã奜ãŸãããæäžéã¯æ£
è ã®çç¶ãšæäžæ¹æ³ã«ãã€ãŠå€ããã
æ¬æ现æžã§äœ¿çšãããçšèªã®æ£è
ã¯ãæž©è¡å
ç©ãäŸãã°ã«ããšããšäžé¢é³¥ã®ãããªé³¥é¡ãåã³
éé·é¡ã人éãçŸã銬ãä¹³çãšéçãè±ãç¬ã
ç«ãã©ããåã³ã¯ã€ãããã¿ã®ãããªåºä¹³é¡ãæ
å³ããŠããã
ç©ãäŸãã°ã«ããšããšäžé¢é³¥ã®ãããªé³¥é¡ãåã³
éé·é¡ã人éãçŸã銬ãä¹³çãšéçãè±ãç¬ã
ç«ãã©ããåã³ã¯ã€ãããã¿ã®ãããªåºä¹³é¡ãæ
å³ããŠããã
çµå£æäžã«ã¯ãååç©ãã«ãã»ã«ããã«ãé
å€ããããŒããæ£å€ã溶液ãæžæ¿æ¶²ãåã¯ä¹³æ¿æ¶²
ã®ãããªåºäœåã¯æ¶²äœèª¿æŽå€ã«åŠæ¹ã§ãããåºäœ
åäœé©é圢åŒã¯ãäŸãã°æœ€æ»å€ãšãä¹³ç³ã庶ç³å
ã³ãšããããã殿ç²ã®ãããªäžæŽ»æ§å å¡«å€ãå«æ
ããéåžžã®ãŒã©ãã³åã®ãã®ã§ããããã«ãã»ã«
圢ã§ããåŸããããäžã€ã®å®æœæ æ§ã§ã¯ãã¢ã©ã
ã¢ãŽã ããšããããã殿ç²åã¯ãŒã©ãã³ã®ãããª
çµåå€ãããããã殿ç²åã¯ã¢ã«ã®ãã³é žã®ãã
ãªåŽ©å£å€ãåã³ã¹ãã¢ãªã³é žåã¯ã¹ãã¢ãªã³é žã
ã°ãã·ãŠã ã®ãããªæœ€æ»å€ãšçµã¿åããä¹³ç³ã庶
ç³ãåã³ãšããããã殿ç©ãããªæ £çšã®é å€åºå€
ãšäžç·ã«æ¬çºæååç©é¡ãé å€åã§ããã
å€ããããŒããæ£å€ã溶液ãæžæ¿æ¶²ãåã¯ä¹³æ¿æ¶²
ã®ãããªåºäœåã¯æ¶²äœèª¿æŽå€ã«åŠæ¹ã§ãããåºäœ
åäœé©é圢åŒã¯ãäŸãã°æœ€æ»å€ãšãä¹³ç³ã庶ç³å
ã³ãšããããã殿ç²ã®ãããªäžæŽ»æ§å å¡«å€ãå«æ
ããéåžžã®ãŒã©ãã³åã®ãã®ã§ããããã«ãã»ã«
圢ã§ããåŸããããäžã€ã®å®æœæ æ§ã§ã¯ãã¢ã©ã
ã¢ãŽã ããšããããã殿ç²åã¯ãŒã©ãã³ã®ãããª
çµåå€ãããããã殿ç²åã¯ã¢ã«ã®ãã³é žã®ãã
ãªåŽ©å£å€ãåã³ã¹ãã¢ãªã³é žåã¯ã¹ãã¢ãªã³é žã
ã°ãã·ãŠã ã®ãããªæœ€æ»å€ãšçµã¿åããä¹³ç³ã庶
ç³ãåã³ãšããããã殿ç©ãããªæ £çšã®é å€åºå€
ãšäžç·ã«æ¬çºæååç©é¡ãé å€åã§ããã
éçµå£æäžã«ã¯ãæ°Žãæ²¹ã®ãããªç¡è液äœã®è¬
åŠæ äœã«è¡šé¢æŽ»æ§å€ãã®ä»ã®è¬åŠçã«åå ¥ããã
ãå©å€ãæ·»å ããŠãåã¯æ·»å ããã«ããã®æ äœã
䌎ã€ãŠççåŠçã«åå ¥ããããåžéå€äžã«ããã
ååç©ã®æº¶æ¶²åã¯æžæ¿æ¶²ã®æ³šå°ã§ããé©éãšããŠ
ååç©ãæäžã§ããããããã®èª¿è£œå€äžã«äœ¿çšã§
ããæ²¹ã®äŸã¯ãç³æ²¹ãåæ€ç©åã¯åæèµ·æºã®ã
ã®ãäŸãã°èœè±çæ²¹ã倧è±æ²¹ãåã³é±æ²¹ã§ããã
äžè¬ã«ãæ°Žãé£å¡©æ°Žãããã¹ãããŒã¹æ°Žæº¶æ¶²åã³
é¢é£ã®ç³æº¶æ¶²ããšã¿ããŒã«ãåã³ãããã¬ã³ã°ãª
ã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ã®ãããªã°ãªã³
ãŒã«é¡ã泚å°æ¶²çšã®æ¶²äœæ äœãšããŠäœ¿çšã§ããã
ç¹ã«å¥œãŸãããã®ã¯ããšã¿ããŒã«æ°Žæº¶æ¶²ããã¢ã«
ã«ãªpHã®ãããã¬ã³ã°ãªã³ãŒã«âãšã¿ããŒã«æ°Ž
溶液ã®ãããªäžã®æ äœãçµã¿åããããã®ã§ã
ãã
åŠæ äœã«è¡šé¢æŽ»æ§å€ãã®ä»ã®è¬åŠçã«åå ¥ããã
ãå©å€ãæ·»å ããŠãåã¯æ·»å ããã«ããã®æ äœã
䌎ã€ãŠççåŠçã«åå ¥ããããåžéå€äžã«ããã
ååç©ã®æº¶æ¶²åã¯æžæ¿æ¶²ã®æ³šå°ã§ããé©éãšããŠ
ååç©ãæäžã§ããããããã®èª¿è£œå€äžã«äœ¿çšã§
ããæ²¹ã®äŸã¯ãç³æ²¹ãåæ€ç©åã¯åæèµ·æºã®ã
ã®ãäŸãã°èœè±çæ²¹ã倧è±æ²¹ãåã³é±æ²¹ã§ããã
äžè¬ã«ãæ°Žãé£å¡©æ°Žãããã¹ãããŒã¹æ°Žæº¶æ¶²åã³
é¢é£ã®ç³æº¶æ¶²ããšã¿ããŒã«ãåã³ãããã¬ã³ã°ãª
ã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ã®ãããªã°ãªã³
ãŒã«é¡ã泚å°æ¶²çšã®æ¶²äœæ äœãšããŠäœ¿çšã§ããã
ç¹ã«å¥œãŸãããã®ã¯ããšã¿ããŒã«æ°Žæº¶æ¶²ããã¢ã«
ã«ãªpHã®ãããã¬ã³ã°ãªã³ãŒã«âãšã¿ããŒã«æ°Ž
溶液ã®ãããªäžã®æ äœãçµã¿åããããã®ã§ã
ãã
ååç©ããã泚å°åã¯ç§»æ€èª¿è£œå€ã®åœ¢ã§æäžã§
ããããããã¯æŽ»æ§æåã®æç¶çãªæŸåºãå¯èœãš
ãããããªæ¹æ³ã§åŠæ¹ã§ããã掻æ§æåã¯ããã¬
ããåã¯å°åç圢ã«å§çž®ããããã泚å°åã¯ç§»æ€
çãšããŠç®äžåã¯çèå ã«ç§»æ€ã§ããã移æ€çã¯
çç©ã«ããå解å¯èœãªéåäœåã¯åæã·ãªã³ãŒã³
é¡ãäŸãã°ã·ã©ã¹ããã¯ãããªãã¡ããŠã»ã³ãŒã
ã³ã°ç€Ÿã®è£œé ã«ããã·ãªã³ãŒã³ãŽã ãã®ãããªäž
掻æ§ææã䜿çšã§ããã
ããããããã¯æŽ»æ§æåã®æç¶çãªæŸåºãå¯èœãš
ãããããªæ¹æ³ã§åŠæ¹ã§ããã掻æ§æåã¯ããã¬
ããåã¯å°åç圢ã«å§çž®ããããã泚å°åã¯ç§»æ€
çãšããŠç®äžåã¯çèå ã«ç§»æ€ã§ããã移æ€çã¯
çç©ã«ããå解å¯èœãªéåäœåã¯åæã·ãªã³ãŒã³
é¡ãäŸãã°ã·ã©ã¹ããã¯ãããªãã¡ããŠã»ã³ãŒã
ã³ã°ç€Ÿã®è£œé ã«ããã·ãªã³ãŒã³ãŽã ãã®ãããªäž
掻æ§ææã䜿çšã§ããã
以äžã¯æ¬çºæã®å®æœã«äœ¿çšã§ããäŸç€ºçãªè¬åŠ
åŠæ¹å€ã§ããã
åŠæ¹å€ã§ããã
é å€åŠæ¹å€ã®èª¿è£œ
ïŒé åœã
ïœïŒ ãšãã«ïŒïŒïŒâãžãããâïŒâãïŒïŒâããš
ãã«âïŒâãããªãžã«ïŒã¡ãã«ãâïŒâãªããœ
â1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒã
100mg ïœïŒ ãšãããããæ®¿ç² 15mg ïœïŒ ä¹³ç³ 33.5mg ïœïŒ ã¹ãã¢ãªã³é žãã°ãã·ãŠã 1.5mg éçµå£åŠæ¹å€ã®èª¿è£œ ïœïŒ ãšãã«ïŒïŒïŒâãžãããâïŒâãïŒïŒâããš
ãã«âïŒâãããªãžãã«ïŒã¡ãã«ãâïŒâãªã
ãœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒ
ã 0.100g ïœïŒ æ°Žé žåãããªãŠã 0.025g ïœïŒ ãšã¿ããŒã« 1.516g ïœïŒ ãããã¬ã³ã°ãªã³ãŒã« 8.264g ïœ ïŒ æ³šå°çšæ°Ž å šäœã§20000ml 次ã®å®æœäŸã¯æ¬çºæã«äœ¿çšãããååç©é¡ã®èª¿
補ãäŸç€ºããããã«èšèŒãããŠãããããããªã
圢ã«ãããŠãéå®çã«èããããŠã¯ãªããªãã
ãã«âïŒâãããªãžã«ïŒã¡ãã«ãâïŒâãªããœ
â1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒã
100mg ïœïŒ ãšãããããæ®¿ç² 15mg ïœïŒ ä¹³ç³ 33.5mg ïœïŒ ã¹ãã¢ãªã³é žãã°ãã·ãŠã 1.5mg éçµå£åŠæ¹å€ã®èª¿è£œ ïœïŒ ãšãã«ïŒïŒïŒâãžãããâïŒâãïŒïŒâããš
ãã«âïŒâãããªãžãã«ïŒã¡ãã«ãâïŒâãªã
ãœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒ
ã 0.100g ïœïŒ æ°Žé žåãããªãŠã 0.025g ïœïŒ ãšã¿ããŒã« 1.516g ïœïŒ ãããã¬ã³ã°ãªã³ãŒã« 8.264g ïœ ïŒ æ³šå°çšæ°Ž å šäœã§20000ml 次ã®å®æœäŸã¯æ¬çºæã«äœ¿çšãããååç©é¡ã®èª¿
補ãäŸç€ºããããã«èšèŒãããŠãããããããªã
圢ã«ãããŠãéå®çã«èããããŠã¯ãªããªãã
èª¿è£œäŸ ïŒ
ãšã¿ããŒã«400mlãš2Nå¡©é
ž100mläžã®ïŒ®ïŒïŒ®â
ãžã¡ãã«âïŒâïŒããããã·ã€ããïŒâïŒâãªããœ
ãã¿ã³ã¢ãã15.8gã®æº¶æ¶²ãããŒæ¯ãšãåšäžã§æš
çäžã®ïŒïŒ ãã©ãžãŠã 觊åª2gäžã§æ°ŽçŽ æ·»å ãã
æ°ŽçŽ ïŒã¢ã«åœéãæåãããïŒïŒãïŒæéïŒã次
ã«åå¿æ··åç©ããéããŠè§Šåªãé€ããæ°Ž80mläžã®
ã·ã¢ã³åã«ãªãŠã 16.2gã®æº¶æ¶²ãå ãããçãã
溶液ãïŒæééæµããã次ãã§åºäœãçµæ¶åãã
ãŸã§æ¿çž®ãããåºäœããéã«ãã€ãŠåé¢ãã50ïŒ
ãšã¿ããŒã«æ°Žæº¶æ¶²ããåçµæ¶ããããšã300âã
è¶ããèç¹ããã€ïŒïŒïŒâãžãããâïŒïŒ®ïŒïŒ
âããªã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãããçãããèç¹300â以äžã
ãžã¡ãã«âïŒâïŒããããã·ã€ããïŒâïŒâãªããœ
ãã¿ã³ã¢ãã15.8gã®æº¶æ¶²ãããŒæ¯ãšãåšäžã§æš
çäžã®ïŒïŒ ãã©ãžãŠã 觊åª2gäžã§æ°ŽçŽ æ·»å ãã
æ°ŽçŽ ïŒã¢ã«åœéãæåãããïŒïŒãïŒæéïŒã次
ã«åå¿æ··åç©ããéããŠè§Šåªãé€ããæ°Ž80mläžã®
ã·ã¢ã³åã«ãªãŠã 16.2gã®æº¶æ¶²ãå ãããçãã
溶液ãïŒæééæµããã次ãã§åºäœãçµæ¶åãã
ãŸã§æ¿çž®ãããåºäœããéã«ãã€ãŠåé¢ãã50ïŒ
ãšã¿ããŒã«æ°Žæº¶æ¶²ããåçµæ¶ããããšã300âã
è¶ããèç¹ããã€ïŒïŒïŒâãžãããâïŒïŒ®ïŒïŒ
âããªã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãããçãããèç¹300â以äžã
é©åœãªçœ®æïŒâïŒããããã·ã€ããïŒâïŒâãªã
ãœãã¿ã³ã¢ããã䜿çšããŠäžã®æé ãããè¿ã
ãšã次ã®ååç©ãåŸãããã
ãœãã¿ã³ã¢ããã䜿çšããŠäžã®æé ãããè¿ã
ãšã次ã®ååç©ãåŸãããã
ïŒïŒïŒâãžãããâïŒïŒâãžã¡ãã«âïŒâãª
ããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµããã
èç¹300âããé«ãã
ããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµããã
èç¹300âããé«ãã
ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâãªããœâ
1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãããèç¹
300âããé«ãã
1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãããèç¹
300âããé«ãã
âïŒç¬¬äžããã«ïŒâïŒïŒïŒâãžãããâïŒâã¡
ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«
ã«ãããµããã
ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«
ã«ãããµããã
ïŒïŒïŒâãžãããâïŒâãšãã«âïŒïŒ®âãžã¡
ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«
ã«ãããµããã
ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«
ã«ãããµããã
èª¿è£œäŸ ïŒ
é
¢é
ž30mlãšç¡æ°Žé
¢é
ž10mläžã«ãããïŒâïŒãã
ããã·ã€ããïŒïŒ®âïŒïŒâã¡ããã·ããšãã«ïŒâïŒ
âãªããœãã¿ã³ã¢ãã11.8gã®ãããŸãã溶液ã«ã
20ã30âã§äºéæ«110gãå ããæ··åç©ãïŒæé
ãããŸãããæ°Ž150mlãå ããæ··åç©ãïŒæéã
ããŸããäºéããéã«ãã€ãŠé€å»ãããæžå§äžã«
溶åªãã液ããèžçºãããçããæ®çç©ãã¡ã¿ã
ãŒã«ããåçµæ¶ããããšãïŒâã¢ã»ãã«ã¢ããâ
âïŒïŒâã¡ããã·ããšãã«ïŒâïŒâãªããœãã¿ã³
ã¢ãããçããã
ããã·ã€ããïŒïŒ®âïŒïŒâã¡ããã·ããšãã«ïŒâïŒ
âãªããœãã¿ã³ã¢ãã11.8gã®ãããŸãã溶液ã«ã
20ã30âã§äºéæ«110gãå ããæ··åç©ãïŒæé
ãããŸãããæ°Ž150mlãå ããæ··åç©ãïŒæéã
ããŸããäºéããéã«ãã€ãŠé€å»ãããæžå§äžã«
溶åªãã液ããèžçºãããçããæ®çç©ãã¡ã¿ã
ãŒã«ããåçµæ¶ããããšãïŒâã¢ã»ãã«ã¢ããâ
âïŒïŒâã¡ããã·ããšãã«ïŒâïŒâãªããœãã¿ã³
ã¢ãããçããã
åç¯ã§åŸãããçæç©10.6gã6Nå¡©é
ž20mläžã«
溶解ãã溶液ã宀枩ã§ïŒåéæŸçœ®ãããæ°Ž80mläž
ã®ã·ã¢ã³åã«ãªãŠã 9.7gã®æº¶æ¶²ãå ããæ··åç©ã
宀枩ã§16æéãããŸãããçæããæ²æ®¿ç©ããé
ã«ãã€ãŠåé¢ãã50ïŒ ãšã¿ããŒã«æ°Žæº¶æ¶²ããïŒå
åçµæ¶ããããšãèç¹çŽ299ã301âïŒå解ïŒã®
ïŒïŒïŒâãžãããââïŒïŒâã¡ããã·ããšãã«ïŒ
âïŒâã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãããçããã
溶解ãã溶液ã宀枩ã§ïŒåéæŸçœ®ãããæ°Ž80mläž
ã®ã·ã¢ã³åã«ãªãŠã 9.7gã®æº¶æ¶²ãå ããæ··åç©ã
宀枩ã§16æéãããŸãããçæããæ²æ®¿ç©ããé
ã«ãã€ãŠåé¢ãã50ïŒ ãšã¿ããŒã«æ°Žæº¶æ¶²ããïŒå
åçµæ¶ããããšãèç¹çŽ299ã301âïŒå解ïŒã®
ïŒïŒïŒâãžãããââïŒïŒâã¡ããã·ããšãã«ïŒ
âïŒâã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãããçããã
é©åœãªïŒ®â眮æïŒâïŒããããã·ã€ããïŒâïŒâ
ãªããœãã¿ã³ã¢ããã䜿çšããŠäžã®æé ãããè¿
ããšã次ã®ååç©ãåŸãããã
ãªããœãã¿ã³ã¢ããã䜿çšããŠäžã®æé ãããè¿
ããšã次ã®ååç©ãåŸãããã
ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâãªããœâ
âããšãã«â1Hâã€ãããŸãŒã«âïŒâã«ã«ã
ããµãã ïŒïŒïŒâãžãããâïŒâã¡ãã«ââïŒïŒïŒïŒ
âãžã¡ãã«ããšãã«ïŒâïŒâãªããœâ1Hâã€ãã
ãŸãŒã«âïŒâã«ã«ãããµãã ïŒïŒïŒâãžãããâïŒâãšãã«âïŒâãªããœâ
âããšãã«â1Hâã€ãããŸãŒã«âïŒâã«ã«ã
ããµãã èª¿è£œäŸ ïŒ ãšãã«ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâãª
ããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒ
ã54.5gãšç¡æ°Žé ¢é ž240mlã®æ··åç©ã13æééæµã
ãããç¡æ°Žé ¢é žãšé ¢é ž150mlãé€ãããã«æ··åç©
ãèžçããããã«æ°ããç¡æ°Žé ¢é žã足ããŠéæµã
åã³ç¶ãããèš22æéã®éæµåŸãéå°ã®ç¡æ°Žé ¢é ž
ãæžå§äžã«èžçºãããçããæ®çç©ãã·ã¯ããã
ãµã³ã§ããç ããã·ã¯ããããµã³ããåçµæ¶ãã
ããšãèç¹çŽ56ã58âã®ãšãã«ïŒïŒïŒâãžã¢ã»ã
ã«âïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâãªããœ
â1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒãã
çããã
âããšãã«â1Hâã€ãããŸãŒã«âïŒâã«ã«ã
ããµãã ïŒïŒïŒâãžãããâïŒâã¡ãã«ââïŒïŒïŒïŒ
âãžã¡ãã«ããšãã«ïŒâïŒâãªããœâ1Hâã€ãã
ãŸãŒã«âïŒâã«ã«ãããµãã ïŒïŒïŒâãžãããâïŒâãšãã«âïŒâãªããœâ
âããšãã«â1Hâã€ãããŸãŒã«âïŒâã«ã«ã
ããµãã èª¿è£œäŸ ïŒ ãšãã«ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâãª
ããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒ
ã54.5gãšç¡æ°Žé ¢é ž240mlã®æ··åç©ã13æééæµã
ãããç¡æ°Žé ¢é žãšé ¢é ž150mlãé€ãããã«æ··åç©
ãèžçããããã«æ°ããç¡æ°Žé ¢é žã足ããŠéæµã
åã³ç¶ãããèš22æéã®éæµåŸãéå°ã®ç¡æ°Žé ¢é ž
ãæžå§äžã«èžçºãããçããæ®çç©ãã·ã¯ããã
ãµã³ã§ããç ããã·ã¯ããããµã³ããåçµæ¶ãã
ããšãèç¹çŽ56ã58âã®ãšãã«ïŒïŒïŒâãžã¢ã»ã
ã«âïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâãªããœ
â1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒãã
çããã
ç¡æ°Žé
¢é
žãšé©åœãªçœ®æïŒïŒïŒâãžãããâïŒâ
ãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãã³é žèª
å°äœã䜿çšããŠäžã®æé ãããè¿ããšã次ã®åå
ç©ãåŸãããã
ãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãã³é žèª
å°äœã䜿çšããŠäžã®æé ãããè¿ããšã次ã®åå
ç©ãåŸãããã
ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒ
ïŒïŒâããªã¡ãã«âïŒâãªããœâ1Hâã€ãã
ãŸãŒã«âïŒâã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒ
ïŒâãžã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâ
ã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâ
ã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«ââïŒç¬¬äžããã«ïŒâïŒïŒ
ïŒâãžãããâïŒâã¡ãã«âïŒâãªããœâ1Hâ
ã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâ
ãšãã«âïŒïŒ®âãžã¡ãã«âïŒâãªããœâ1Hâ
ã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããââ
ïŒïŒâã¡ããã·ããšãã«ïŒâïŒâã¡ãã«âïŒâãªã
ãœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâ
ã¡ãã«âïŒâãªããœââããšãã«â1Hâã€ã
ããŸãŒã«âïŒâã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâ
ã¡ãã«ââïŒïŒïŒïŒâãžã¡ãã«ããšãã«ïŒâïŒâ
ãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµã
ã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâ
ãšãã«âïŒâãªããœââããšãã«â1Hâã€ã
ããŸãŒã«âïŒâã«ã«ãããµãã èª¿è£œäŸ ïŒ åå¡©åççŽ 400mläžã«ããããšãã«ïŒïŒïŒâãž
ã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâ
ãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬
ãŒã12.7gïŒ0.050ã¢ã«ïŒãâããã¢ãµã¯ã·ã³ã€ã
ã9.3gïŒ0.052ã¢ã«ïŒåã³éé žåãã³ãŸã€ã«çŽ100
mgã®æ··åç©ãéæµæž©åºŠã§ïŒæéãããŸãããæ··å
ç©ãå·åŽããçæãããµã¯ã·ã³ã€ãããé€ããã
ã«ãéãããã液ãã溶åªãèžçºããããšãïŒâ
ïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâ
ãžãããâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒ
âã«ã«ããã·ã¬ãŒããæ²¹ãšããŠçããã
ïŒïŒâããªã¡ãã«âïŒâãªããœâ1Hâã€ãã
ãŸãŒã«âïŒâã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒ
ïŒâãžã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâ
ã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâ
ã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«ââïŒç¬¬äžããã«ïŒâïŒïŒ
ïŒâãžãããâïŒâã¡ãã«âïŒâãªããœâ1Hâ
ã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâ
ãšãã«âïŒïŒ®âãžã¡ãã«âïŒâãªããœâ1Hâ
ã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããââ
ïŒïŒâã¡ããã·ããšãã«ïŒâïŒâã¡ãã«âïŒâãªã
ãœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâ
ã¡ãã«âïŒâãªããœââããšãã«â1Hâã€ã
ããŸãŒã«âïŒâã«ã«ãããµãã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâ
ã¡ãã«ââïŒïŒïŒïŒâãžã¡ãã«ããšãã«ïŒâïŒâ
ãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµã
ã ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâ
ãšãã«âïŒâãªããœââããšãã«â1Hâã€ã
ããŸãŒã«âïŒâã«ã«ãããµãã èª¿è£œäŸ ïŒ åå¡©åççŽ 400mläžã«ããããšãã«ïŒïŒïŒâãž
ã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâ
ãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬
ãŒã12.7gïŒ0.050ã¢ã«ïŒãâããã¢ãµã¯ã·ã³ã€ã
ã9.3gïŒ0.052ã¢ã«ïŒåã³éé žåãã³ãŸã€ã«çŽ100
mgã®æ··åç©ãéæµæž©åºŠã§ïŒæéãããŸãããæ··å
ç©ãå·åŽããçæãããµã¯ã·ã³ã€ãããé€ããã
ã«ãéãããã液ãã溶åªãèžçºããããšãïŒâ
ïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâ
ãžãããâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒ
âã«ã«ããã·ã¬ãŒããæ²¹ãšããŠçããã
âããã¢ãµã¯ã·ã³ã€ãããšé©åœãªçœ®æïŒïŒïŒ
âãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâãªããœâ
1Hâã€ãããŸãŒã«âïŒâã«ã«ãã³é žèªå°äœã䜿
çšããŠäžã®æé ãããè¿ããšã次ã®ååç©ãåŸã
ããã
âãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâãªããœâ
1Hâã€ãããŸãŒã«âïŒâã«ã«ãã³é žèªå°äœã䜿
çšããŠäžã®æé ãããè¿ããšã次ã®ååç©ãåŸã
ããã
ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«â
ïŒïŒïŒâãžãããâïŒïŒ®âãžã¡ãã«âïŒâãªã
ãœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«â
ïŒïŒïŒâãžãããââã¡ãã«âïŒâãªããœâ
1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«â
ïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€ãããŸ
ãŒã«âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒââïŒç¬¬äžããã«ïŒâïŒïŒ
ïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâãªããœ
â1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒïŒâããã¢ãšãã«ïŒâïŒïŒïŒâãžãããâ
ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒ®âãžã¡ãã«âïŒâãª
ããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«â
ïŒïŒïŒâãžãããââïŒïŒâã¡ããã·ããšãã«ïŒ
âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ã
ããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«â
ïŒïŒïŒâãžãããâïŒâãªããœââããšãã«â
1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«â
ïŒïŒïŒâãžãããââïŒïŒïŒïŒâãžã¡ãã«ããš
ãã«ïŒâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«
ã«ãããµãã ïŒâïŒïŒâããã¢ãšãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«
âïŒïŒïŒâãžãããâïŒâãªããœââããšãã«
â1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ãšãã«ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžããã
âïŒïŒïŒâãžã¡ãã«âïŒâãªããœâ1Hâã€ãã
ãŸãŒã«âïŒâã«ã«ããã·ã¬ãŒã èª¿è£œäŸ ïŒ ç²è£œãšãã«ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢
ã»ãã«âïŒïŒïŒâãžãããâïŒâãªããœâ1Hâ
ã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒããé ¢é žäžã®
30ïŒ èåæ°ŽçŽ é žã«æº¶è§£ãã溶液ã宀枩ã§ïŒæéæŸ
眮ãããæ²æ®¿ããåºäœããéã«ãã€ãŠåé¢ããæ°Ž
é žåã«ãªãŠã äžã§80âã®ç空äžã§ä¹Ÿç¥ãããšãè
ç¹çŽ193ã194âïŒå解ïŒã®ãšãã«ïŒâã¢ã»ãã«â
ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžãããâïŒâãª
ããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒ
ããçããã
ïŒïŒïŒâãžãããâïŒïŒ®âãžã¡ãã«âïŒâãªã
ãœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«â
ïŒïŒïŒâãžãããââã¡ãã«âïŒâãªããœâ
1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«â
ïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€ãããŸ
ãŒã«âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒââïŒç¬¬äžããã«ïŒâïŒïŒ
ïŒâãžã¢ã»ãã«âïŒïŒïŒâãžãããâïŒâãªããœ
â1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒïŒâããã¢ãšãã«ïŒâïŒïŒïŒâãžãããâ
ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒ®âãžã¡ãã«âïŒâãª
ããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«â
ïŒïŒïŒâãžãããââïŒïŒâã¡ããã·ããšãã«ïŒ
âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ã
ããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«â
ïŒïŒïŒâãžãããâïŒâãªããœââããšãã«â
1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«â
ïŒïŒïŒâãžãããââïŒïŒïŒïŒâãžã¡ãã«ããš
ãã«ïŒâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«
ã«ãããµãã ïŒâïŒïŒâããã¢ãšãã«ïŒâïŒïŒïŒâãžã¢ã»ãã«
âïŒïŒïŒâãžãããâïŒâãªããœââããšãã«
â1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã ãšãã«ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžããã
âïŒïŒïŒâãžã¡ãã«âïŒâãªããœâ1Hâã€ãã
ãŸãŒã«âïŒâã«ã«ããã·ã¬ãŒã èª¿è£œäŸ ïŒ ç²è£œãšãã«ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã¢
ã»ãã«âïŒïŒïŒâãžãããâïŒâãªããœâ1Hâ
ã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒããé ¢é žäžã®
30ïŒ èåæ°ŽçŽ é žã«æº¶è§£ãã溶液ã宀枩ã§ïŒæéæŸ
眮ãããæ²æ®¿ããåºäœããéã«ãã€ãŠåé¢ããæ°Ž
é žåã«ãªãŠã äžã§80âã®ç空äžã§ä¹Ÿç¥ãããšãè
ç¹çŽ193ã194âïŒå解ïŒã®ãšãã«ïŒâã¢ã»ãã«â
ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžãããâïŒâãª
ããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒ
ããçããã
é©åœãªçœ®æïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãžã
ããâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«
ã«ãã³é žèªå°äœã䜿çšããŠäžã®æé ãããè¿ã
ãšã次ã®ååç©ãåŸãããã
ããâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«
ã«ãã³é žèªå°äœã䜿çšããŠäžã®æé ãããè¿ã
ãšã次ã®ååç©ãåŸãããã
ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžãããâïŒ
âãžã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžãããââ
ã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâ
ã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžãããâïŒâ
ãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµã
ã ïŒâïŒããã¢ã¡ãã«ïŒïŒ®âïŒç¬¬äžããã«ïŒâïŒïŒ
ïŒâãžãããâïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãã ïŒâïŒããã¢ãšãã«ïŒâïŒïŒïŒâãžãããâïŒ
âãžã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžãããââ
ïŒïŒâã¡ããã·ããšãã«ïŒâïŒâãªããµâ1Hâã€
ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžãããâïŒâ
ãªããœââããšãã«â1Hâã€ãããŸãŒã«âïŒ
âã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžãããââ
ïŒïŒïŒïŒâãžã¡ãã«ããšãã«ïŒâïŒâãªããœâ1H
âã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒïŒâããã¢ãšãã«ïŒâïŒïŒïŒâãžãããâ
ïŒâãªããœââããšãã«â1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãã å®æœäŸ ïŒ ãšãã«ïŒâã¢ã»ãã«âïŒâïŒããã¢ã¡ãã«ïŒâ
ïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€ãããŸ
ãŒã«âïŒâã«ã«ããã·ã¬ãŒã4.4gïŒ15ã¡ãªã¢ã«ïŒã
ïŒâããšãã«ãããªãžã³2.5gïŒ16ããªã¢ã«ïŒãçé ž
ã«ãªãŠã 2.1gïŒ15ããªã¢ã«ïŒåã³ãšã¿ããŒã«75ml
ã®æ··åç©ã25âã§16æéãããŸãããæ°Ž100mlã
å ããæ²æ®¿ç©ãçæãããããããéã«ãã€ãŠå
é¢ããæ°ŽæŽããã次ã«ãããïŒâãããããŒã«ã«
æžæ¿ããïŒâãããããŒã«äžã«å¡©åæ°ŽçŽ ïŒåœéã
å ãããçããåºäœããéã«ãã€ãŠåé¢ããå°é
ã®æ°Žãå«æããïŒâãããããŒã«ããåçµæ¶ãã
ããšãèç¹çŽ240ãã241âã®ãšãã«ïŒïŒïŒâãžã
ããâïŒâãïŒïŒâããšãã«âïŒâãããªãžãã«ïŒ
ã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâ
ã«ã«ããã·ã¬ãŒãå¡©é žå¡©ãçããã
âãžã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžãããââ
ã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâ
ã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžãããâïŒâ
ãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµã
ã ïŒâïŒããã¢ã¡ãã«ïŒïŒ®âïŒç¬¬äžããã«ïŒâïŒïŒ
ïŒâãžãããâïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãã ïŒâïŒããã¢ãšãã«ïŒâïŒïŒïŒâãžãããâïŒ
âãžã¡ãã«âïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžãããââ
ïŒïŒâã¡ããã·ããšãã«ïŒâïŒâãªããµâ1Hâã€
ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžãããâïŒâ
ãªããœââããšãã«â1Hâã€ãããŸãŒã«âïŒ
âã«ã«ãããµãã ïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžãããââ
ïŒïŒïŒïŒâãžã¡ãã«ããšãã«ïŒâïŒâãªããœâ1H
âã€ãããŸãŒã«âïŒâã«ã«ãããµãã ïŒâïŒïŒâããã¢ãšãã«ïŒâïŒïŒïŒâãžãããâ
ïŒâãªããœââããšãã«â1Hâã€ãããŸãŒã«
âïŒâã«ã«ãããµãã å®æœäŸ ïŒ ãšãã«ïŒâã¢ã»ãã«âïŒâïŒããã¢ã¡ãã«ïŒâ
ïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€ãããŸ
ãŒã«âïŒâã«ã«ããã·ã¬ãŒã4.4gïŒ15ã¡ãªã¢ã«ïŒã
ïŒâããšãã«ãããªãžã³2.5gïŒ16ããªã¢ã«ïŒãçé ž
ã«ãªãŠã 2.1gïŒ15ããªã¢ã«ïŒåã³ãšã¿ããŒã«75ml
ã®æ··åç©ã25âã§16æéãããŸãããæ°Ž100mlã
å ããæ²æ®¿ç©ãçæãããããããéã«ãã€ãŠå
é¢ããæ°ŽæŽããã次ã«ãããïŒâãããããŒã«ã«
æžæ¿ããïŒâãããããŒã«äžã«å¡©åæ°ŽçŽ ïŒåœéã
å ãããçããåºäœããéã«ãã€ãŠåé¢ããå°é
ã®æ°Žãå«æããïŒâãããããŒã«ããåçµæ¶ãã
ããšãèç¹çŽ240ãã241âã®ãšãã«ïŒïŒïŒâãžã
ããâïŒâãïŒïŒâããšãã«âïŒâãããªãžãã«ïŒ
ã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâ
ã«ã«ããã·ã¬ãŒãå¡©é žå¡©ãçããã
å®æœäŸ ïŒ
ïŒâããšãã«ãããªãžã³ãšèª¿è£œäŸïŒåã¯ïŒã§åŸ
ãããé©åœãªïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã
ããâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«
ã«ãã³é žèªå°äœã䜿çšããŠå®æœæœäŸïŒã®æé ãã
ãè¿ããšã次ã®ååç©ãåŸãããã
ãããé©åœãªïŒâïŒããã¢ã¡ãã«ïŒâïŒïŒïŒâãžã
ããâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«
ã«ãã³é žèªå°äœã䜿çšããŠå®æœæœäŸïŒã®æé ãã
ãè¿ããšã次ã®ååç©ãåŸãããã
ïŒïŒïŒâãžãããâïŒâãïŒâïŒâããšãã«âïŒ
âãããªãžãã«ïŒã¡ãã«ãâïŒâãªããœâ1Hâã€
ãããŸãŒã«âïŒâã«ã«ãããµããå¡©é žå¡© ïŒïŒïŒâãžãããââã¡ãã«âïŒâãïŒïŒâã
ãšãã«âïŒâãããªãžãã«ïŒã¡ãã«ãâïŒâãªã
ãœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµããå¡©
é žå¡© ïŒïŒïŒâãžãããâïŒïŒ®âãžã¡ãã«âïŒâ
ãïŒïŒâããšãã«âïŒâãããªãžãã«ïŒã¡ãã«ãâ
ïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãã
ãµããå¡©é žå¡© âïŒç¬¬äžããã«ïŒâïŒïŒïŒâãžãããâïŒâ
ãïŒïŒâããšãã«âïŒâãããªãžãã«ïŒã¡ãã«ãâ
ïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãã
ãµããå¡©é žå¡© ïŒïŒïŒâãžãããâïŒïŒ®âãžã¡ãã«âïŒâ
ãïŒâïŒïŒâããšãã«âïŒâãããªãžãã«ïŒâãšã
ã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«
ãããµããå¡©é žå¡© ïŒïŒïŒâãžãããââïŒïŒâã¡ããã·ããšã
ã«ïŒâïŒâãïŒïŒâããšãã«âïŒâãããªãžãã«ïŒ
ã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâ
ã«ã«ãããµããå¡©é žå¡© ïŒïŒïŒâãžãããââããšãã«âïŒâãïŒïŒâ
ããšãã«âïŒâãããªãžãã«ïŒã¡ãã«ãâïŒâãª
ããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã
å¡©é žå¡© ïŒïŒïŒâãžãããââïŒïŒâã¡ãã«ããšãã«ïŒ
âïŒâãïŒïŒâããšãã«âïŒâãããªãžãã«ïŒã¡ã
ã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«
ãããµããå¡©é žå¡© ïŒïŒïŒâãžãããâïŒâãïŒïŒâããšãã«âïŒâ
ãããªãžãã«ïŒã¡ãã«ãââïŒïŒïŒïŒâãžã¡ãã«
ããšãã«ïŒâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒ
âã«ã«ãããµããå¡©é žå¡© ïŒïŒïŒâãžãããââããšãã«âïŒâãïŒâ
ïŒïŒâããšãã«âïŒâãããªãžãã«ïŒãšãã«ãâïŒ
âãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµ
ããå¡©é žå¡© ãšãã«ïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«â
ïŒâãïŒïŒâããšãã«âïŒâãããªãžãã«ïŒã¡ã
ã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«
ããã·ã¬ãŒãå¡©é žå¡© å®æœäŸ ïŒ ãšãã«ïŒâã¢ã»ãã«âïŒâïŒããã¢ã¡ãã«ïŒâ
ïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€ãããŸ
ãŒã«âïŒâã«ã«ããã·ã¬ãŒã4.1gïŒ14.2ããªã¢
ã«ïŒãïŒâïŒïŒâã¯ããããšãã«ïŒâïŒâãããã
ã·ãããªãžã³3.0gïŒ14.2ããªã¢ã«ïŒãçé žã«ãªãŠã
2.0gïŒ14.2ããªã¢ã«ïŒåã³ãšã¿ããŒã«75mlã®æ··å
ç©ãã¢ã«ãŽã³äžã«25âã§16æéãããŸãããæ°Ž
100mlãå ããçæããæ²æ®¿ç©ãéããæ°Žã§æŽãã
次ã«ãããïŒâãããããŒã«ã«æžæ¿ããïŒâãã
ãããŒã«äžã®å¡©åæ°ŽçŽ ïŒåœéãå ãããçããåº
äœãåé¢ããïŒâãããããŒã«ãšæ°Žã®æ··åç©ãã
ïŒååçµæ¶ããããšããšãã«ïŒâããïŒâïŒïŒâã¯
ããããšãã«ïŒâïŒâããããã·âïŒâãããªãž
ãã«ãã¡ãã«ãâïŒïŒïŒâãžãããâïŒâãªããœ
â1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒãå¡©
é žå¡©ãçããã
âãããªãžãã«ïŒã¡ãã«ãâïŒâãªããœâ1Hâã€
ãããŸãŒã«âïŒâã«ã«ãããµããå¡©é žå¡© ïŒïŒïŒâãžãããââã¡ãã«âïŒâãïŒïŒâã
ãšãã«âïŒâãããªãžãã«ïŒã¡ãã«ãâïŒâãªã
ãœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµããå¡©
é žå¡© ïŒïŒïŒâãžãããâïŒïŒ®âãžã¡ãã«âïŒâ
ãïŒïŒâããšãã«âïŒâãããªãžãã«ïŒã¡ãã«ãâ
ïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãã
ãµããå¡©é žå¡© âïŒç¬¬äžããã«ïŒâïŒïŒïŒâãžãããâïŒâ
ãïŒïŒâããšãã«âïŒâãããªãžãã«ïŒã¡ãã«ãâ
ïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãã
ãµããå¡©é žå¡© ïŒïŒïŒâãžãããâïŒïŒ®âãžã¡ãã«âïŒâ
ãïŒâïŒïŒâããšãã«âïŒâãããªãžãã«ïŒâãšã
ã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«
ãããµããå¡©é žå¡© ïŒïŒïŒâãžãããââïŒïŒâã¡ããã·ããšã
ã«ïŒâïŒâãïŒïŒâããšãã«âïŒâãããªãžãã«ïŒ
ã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâ
ã«ã«ãããµããå¡©é žå¡© ïŒïŒïŒâãžãããââããšãã«âïŒâãïŒïŒâ
ããšãã«âïŒâãããªãžãã«ïŒã¡ãã«ãâïŒâãª
ããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµãã
å¡©é žå¡© ïŒïŒïŒâãžãããââïŒïŒâã¡ãã«ããšãã«ïŒ
âïŒâãïŒïŒâããšãã«âïŒâãããªãžãã«ïŒã¡ã
ã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«
ãããµããå¡©é žå¡© ïŒïŒïŒâãžãããâïŒâãïŒïŒâããšãã«âïŒâ
ãããªãžãã«ïŒã¡ãã«ãââïŒïŒïŒïŒâãžã¡ãã«
ããšãã«ïŒâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒ
âã«ã«ãããµããå¡©é žå¡© ïŒïŒïŒâãžãããââããšãã«âïŒâãïŒâ
ïŒïŒâããšãã«âïŒâãããªãžãã«ïŒãšãã«ãâïŒ
âãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãããµ
ããå¡©é žå¡© ãšãã«ïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«â
ïŒâãïŒïŒâããšãã«âïŒâãããªãžãã«ïŒã¡ã
ã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«
ããã·ã¬ãŒãå¡©é žå¡© å®æœäŸ ïŒ ãšãã«ïŒâã¢ã»ãã«âïŒâïŒããã¢ã¡ãã«ïŒâ
ïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€ãããŸ
ãŒã«âïŒâã«ã«ããã·ã¬ãŒã4.1gïŒ14.2ããªã¢
ã«ïŒãïŒâïŒïŒâã¯ããããšãã«ïŒâïŒâãããã
ã·ãããªãžã³3.0gïŒ14.2ããªã¢ã«ïŒãçé žã«ãªãŠã
2.0gïŒ14.2ããªã¢ã«ïŒåã³ãšã¿ããŒã«75mlã®æ··å
ç©ãã¢ã«ãŽã³äžã«25âã§16æéãããŸãããæ°Ž
100mlãå ããçæããæ²æ®¿ç©ãéããæ°Žã§æŽãã
次ã«ãããïŒâãããããŒã«ã«æžæ¿ããïŒâãã
ãããŒã«äžã®å¡©åæ°ŽçŽ ïŒåœéãå ãããçããåº
äœãåé¢ããïŒâãããããŒã«ãšæ°Žã®æ··åç©ãã
ïŒååçµæ¶ããããšããšãã«ïŒâããïŒâïŒïŒâã¯
ããããšãã«ïŒâïŒâããããã·âïŒâãããªãž
ãã«ãã¡ãã«ãâïŒïŒïŒâãžãããâïŒâãªããœ
â1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒãå¡©
é žå¡©ãçããã
å®æœäŸ ïŒ
ãšãã«ïŒâã¢ã»ãã«âïŒâïŒããã¢ã¡ãã«ïŒâ
ïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€ãããŸ
ãŒã«âïŒâã«ã«ããã·ã¬ãŒãåã³é©åœãªïŒâ眮æ
ãããªãžã³ã䜿çšããŠå®æœäŸïŒã®æé ãããè¿ã
ãšã次ã®ååç©ãåŸãããã
ïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€ãããŸ
ãŒã«âïŒâã«ã«ããã·ã¬ãŒãåã³é©åœãªïŒâ眮æ
ãããªãžã³ã䜿çšããŠå®æœäŸïŒã®æé ãããè¿ã
ãšã次ã®ååç©ãåŸãããã
ãšãã«ïŒïŒïŒâãžãããâïŒâãïŒïŒâããšãã«
âïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒâããªãžã
ã«ïŒã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«â
ïŒâã«ã«ããã·ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâããïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒ
ïŒïŒïŒïŒïŒâããã©ãããâïŒâããªãžãã«ãã¡
ãã«ãâïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€
ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâãïŒïŒâã¢ã»ãã«âïŒâããšãã«âïŒ
âãããªãžãã«ïŒã¡ãã«ãâïŒïŒïŒâãžãããâ
ïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãã
ã·ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâãïŒïŒâã·ã¢ãâïŒâããšãã«âïŒâ
ãããªãžãã«ïŒã¡ãã«ãâïŒïŒïŒâãžãããâïŒ
âãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·
ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâãïŒïŒâãšããã·ã«ã«ããã«âïŒâã
ãšãã«âïŒâãããªãžãã«ïŒã¡ãã«ãâïŒïŒïŒâ
ãžãããâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒ
âã«ã«ããã·ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâããïŒâãšããã·ã«ã«ããã«âïŒâ
ïŒïŒâã¯ããããšãã«ïŒâïŒâãããªãžãã«ãã¡ã
ã«ãâïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€ã
ããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâããïŒâããããã·âïŒâïŒïŒâã¡ã
ã«ããšãã«ïŒâïŒâãããªãžãã«ãã¡ãã«ãâïŒïŒ
ïŒâãžãããâïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ããã·ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâããïŒâããããã·âïŒâïŒïŒâããª
ãã«ãªãã¡ãã«ããšãã«ïŒâïŒâãããªãžãã«ã
ã¡ãã«ãâïŒïŒïŒâãžãããâïŒâãªããœâ1Hâ
ã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒãå¡©é žå¡© å®æœäŸ ïŒ ãšãã«ïŒïŒïŒâãžãããâïŒâãïŒïŒâããšãã«
âïŒâãããªãžãã«ïŒã¡ãã«ãâïŒâãªããœâ1H
âã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒãå¡©é žå¡©ã
æšæºæé ã«ãã€ãŠéé¢å¡©åºãžè»¢åãã次ã«å€§éå°
ã®éæµããç¡æ°Žé ¢é žã§ïŒæéåŠçãããéå°éã®
ç¡æ°Žé ¢é žãæžå§äžã«èžçºãããçããæ®çç©ãé ¢
é žãšãã«ãšãšã¿ããŒã«ã®æ··åç©ããïŒååçµæ¶ã
ãããšããšãã«ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãž
ãããâïŒâãïŒïŒâããšãã«âïŒâãããªãžã
ã«ïŒã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«â
ïŒâã«ã«ããã·ã¬ãŒããçããã
âïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒâããªãžã
ã«ïŒã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«â
ïŒâã«ã«ããã·ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâããïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒ
ïŒïŒïŒïŒïŒâããã©ãããâïŒâããªãžãã«ãã¡
ãã«ãâïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€
ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâãïŒïŒâã¢ã»ãã«âïŒâããšãã«âïŒ
âãããªãžãã«ïŒã¡ãã«ãâïŒïŒïŒâãžãããâ
ïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ãã
ã·ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâãïŒïŒâã·ã¢ãâïŒâããšãã«âïŒâ
ãããªãžãã«ïŒã¡ãã«ãâïŒïŒïŒâãžãããâïŒ
âãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·
ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâãïŒïŒâãšããã·ã«ã«ããã«âïŒâã
ãšãã«âïŒâãããªãžãã«ïŒã¡ãã«ãâïŒïŒïŒâ
ãžãããâïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒ
âã«ã«ããã·ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâããïŒâãšããã·ã«ã«ããã«âïŒâ
ïŒïŒâã¯ããããšãã«ïŒâïŒâãããªãžãã«ãã¡ã
ã«ãâïŒïŒïŒâãžãããâïŒâãªããœâ1Hâã€ã
ããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâããïŒâããããã·âïŒâïŒïŒâã¡ã
ã«ããšãã«ïŒâïŒâãããªãžãã«ãã¡ãã«ãâïŒïŒ
ïŒâãžãããâïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ããã·ã¬ãŒãå¡©é žå¡© ãšãã«ïŒâããïŒâããããã·âïŒâïŒïŒâããª
ãã«ãªãã¡ãã«ããšãã«ïŒâïŒâãããªãžãã«ã
ã¡ãã«ãâïŒïŒïŒâãžãããâïŒâãªããœâ1Hâ
ã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒãå¡©é žå¡© å®æœäŸ ïŒ ãšãã«ïŒïŒïŒâãžãããâïŒâãïŒïŒâããšãã«
âïŒâãããªãžãã«ïŒã¡ãã«ãâïŒâãªããœâ1H
âã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒãå¡©é žå¡©ã
æšæºæé ã«ãã€ãŠéé¢å¡©åºãžè»¢åãã次ã«å€§éå°
ã®éæµããç¡æ°Žé ¢é žã§ïŒæéåŠçãããéå°éã®
ç¡æ°Žé ¢é žãæžå§äžã«èžçºãããçããæ®çç©ãé ¢
é žãšãã«ãšãšã¿ããŒã«ã®æ··åç©ããïŒååçµæ¶ã
ãããšããšãã«ïŒïŒïŒâãžã¢ã»ãã«âïŒïŒïŒâãž
ãããâïŒâãïŒïŒâããšãã«âïŒâãããªãžã
ã«ïŒã¡ãã«ãâïŒâãªããœâ1Hâã€ãããŸãŒã«â
ïŒâã«ã«ããã·ã¬ãŒããçããã
å®æœäŸ ïŒ
ãšãã«ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâãª
ããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒ
ãã®ãããªãŠã å¡©ã¯ãã¡ã¿ããŒã«100mläžã®ãšã
ã«ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâãªããœâ
1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒã4.9g
ããããããªãŠã ã¡ããã·ã1.6gã®æ·»å ã«ãã€ãŠ
ã€ããããããã®ãããªãŠã å¡©8.0gããžã¡ãã«ã¹
ã«ããã·ã120mlãåã³æ²åã¡ãã«19.5ïœããæ··
åç©ãã€ããããã®æ··åç©ã宀枩ã§60åãããŸ
ããæ°Ž800mläžã«æ³šããçããæ··åç©ãå¡©åã¡ã
ã¬ã³ã§æœåºãã溶åªãæœåºæ¶²ããèžçºããããšã
ãšãã«ïŒïŒïŒâãžãããâïŒïŒïŒïŒïŒâããªã¡ã
ã«âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«
ããã·ã¬ãŒããçããã
ããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒ
ãã®ãããªãŠã å¡©ã¯ãã¡ã¿ããŒã«100mläžã®ãšã
ã«ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâãªããœâ
1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒã4.9g
ããããããªãŠã ã¡ããã·ã1.6gã®æ·»å ã«ãã€ãŠ
ã€ããããããã®ãããªãŠã å¡©8.0gããžã¡ãã«ã¹
ã«ããã·ã120mlãåã³æ²åã¡ãã«19.5ïœããæ··
åç©ãã€ããããã®æ··åç©ã宀枩ã§60åãããŸ
ããæ°Ž800mläžã«æ³šããçããæ··åç©ãå¡©åã¡ã
ã¬ã³ã§æœåºãã溶åªãæœåºæ¶²ããèžçºããããšã
ãšãã«ïŒïŒïŒâãžãããâïŒïŒïŒïŒïŒâããªã¡ã
ã«âïŒâãªããœâ1Hâã€ãããŸãŒã«âïŒâã«ã«
ããã·ã¬ãŒããçããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ åŒ K0655 ãåŒäžïŒ²ã¯æ°ŽçŽ ãïŒãïŒåã®ççŽ ååã®äœçŽã¢ã«
ãã«ãïŒãïŒåã®ççŽ ååã®äœçŽã¢ã«ã«ãã€ã«ã
åã¯ãã³ãŸã€ã«ã§ãããR1ã¯ããããã·ãïŒã
ïŒåã®ççŽ ååã®äœçŽã¢ã«ã³ãã·ãã¢ãããïŒäœ
çŽã¢ã«ãã«ïŒã¢ãããïŒäœçŽã¢ã«ãã«ïŒ2ã¢ããå
ã¯âNHR5ïŒR5ã¯ããšãã«ãã¡ãã«ããšãã«ããž
ã¡ãã«ããšãã«åã¯ã¡ããã·ããšãã«ïŒã§ããã
R2ã¯æ°ŽçŽ åã¯ïŒãïŒåã®ççŽ ååã®äœçŽã¢ã«ã
ã«ã§ãããã¯æ°ŽçŽ ãããã²ã³ãã¡ãã«ãã¡ãã
ã·åã¯ããªãã«ãªãã¡ãã«ã§ãããã¯æ°ŽçŽ ãã
ãããã·ãã·ã¢ããã¢ã»ãã«åã¯ïŒC1ã4ã®äœçŽã¢
ã«ã³ãã·ïŒã«ã«ããã«ã§ãã€ãŠãY1ã¯æ°ŽçŽ ã§ã
ãããåã¯ïŒ¹ãšY1ã¯äžç·ã«ãªã€ãŠäºéçµåãã€
ãããã®ååç©ãåã¯è£œè¬åŠçã«åå ¥ããããã
ã®é žä»å å¡©ã ïŒ åŒ K0656 ãåŒäžR1ã¯ããããã·ãïŒãïŒåã®ççŽ ååã®
äœçŽã¢ã«ã³ãã·ãã¢ãããïŒäœçŽã¢ã«ãã«ïŒã¢ã
ããïŒäœçŽã¢ã«ãã«ïŒ2ã¢ããåã¯âNHR5ïŒããã§
R5ã¯ããšãã«ãã¡ãã«ããšãã«ããžã¡ãã«ããš
ãã«åã¯ã¡ããã·ããšãã«ïŒã§ãããã¯æ°ŽçŽ ã
ããã²ã³ãã¡ãã«ãã¡ããã·ããããŠããªãã«ãª
ãã¡ãã«ãã¯æ°ŽçŽ ãããããã·ãã·ã¢ããã¢ã»
ãã«åã¯ïŒC1ã4äœçŽã¢ã«ã³ãã·ïŒã«ã«ããã«ã§ã
ããY1ã¯æ°ŽçŽ ã§ããããåã¯ïŒ¹ãšY1ã¯äžç·ã«äº
éçµåãã€ãããããã€ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«
ããååç©ã ïŒ åŒ K0657 ãåŒäžR1ã¯ããããã·ãïŒãïŒåã®ççŽ ååã®
äœçŽã¢ã«ã³ãã·ãã¢ããïŒäœçŽã¢ã«ãã«ïŒã¢ã
ããïŒäœçŽã¢ã«ãã«ïŒ2ã¢ããåã¯âNHR5ïŒããã§
R5ã¯ããšãã«ãã¡ãã«ããšãã«ããžã¡ãã«ããš
ãã«ãåã¯ã¡ããã·ããšãã«ïŒã§ãããããã€ç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«ããååç©ã ïŒ ãšãã«ïŒïŒïŒâãžãããâïŒâãïŒïŒâããšã
ã«âïŒâãããªãžãã«ïŒã¡ãã«ãâïŒâãªããœâ
1Hâã€ãããŸãŒã«âïŒâã«ã«ããã·ã¬ãŒãã§ã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«ããååç©ã ïŒ ãšãã«ïŒâããïŒâïŒïŒâã¯ããããšãã«ïŒâïŒ
âããããã·âïŒâãããªãžãã«ãã¡ãã«ãâïŒïŒ
ïŒâãžãããâïŒâãªããœâ1Hâã€ãããŸãŒã«
âïŒâã«ã«ããã·ã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé ã«ããååç©ã ïŒ (a) åŒ K0658 ãåŒäžïŒ²ã¯æ°ŽçŽ ãïŒãïŒåã®ççŽ ååã®äœçŽã¢ã«
ãã«ã§ãããR1ã¯ããããã·ãïŒãïŒåã®ççŽ
ååã®äœçŽã¢ã«ã³ãã·ãã¢ãããïŒäœçŽã¢ã«ãã«ïŒ
ã¢ãããïŒäœçŽã¢ã«ãã«ïŒ2ã¢ããåã¯âNHR5ïŒã
ãã§R5ã¯ããšãã«ãã¡ãã«ããšãã«ããžã¡ãã«
ããšãã«ãåã¯ã¡ããã·ããšãã«ã§ãããR2ã¯
æ°ŽçŽ åã¯ïŒãïŒåã®ççŽ ååã®äœçŽã¢ã«ãã«ã§ã
ããã®ããã¢ã¢ã«ãã«ååç©ã åŒ K0659 ãåŒäžïŒžã¯æ°ŽçŽ ãããã²ã³ãã¡ãã«ãã¡ããã·å
ã¯ããªãã«ãªãã¡ãã«ã§ãããã¯æ°ŽçŽ ãããã
ãã·ãã·ã¢ããã¢ã»ãã«åã¯ïŒC1ã4äœçŽã¢ã«ã³ã
ã·ïŒã«ã«ããã«ã§ãããY1ã¯æ°ŽçŽ ã§ããããå
ã¯ïŒ¹ãšY1ãäžç·ã«äºéçµåã圢æãããã®ã¢ã
ã³ãšåå¿ããã (b) ç¶ããŠå¿ èŠãªãã°é©åœãªã«ã«ãã³é žã¯ãã©ã€
ãåã¯ç¡æ°Žç©ãšåå¿ãããŠããäœçŽã¢ã«ã«ã
ã€ã«åã¯ãã³ãŸã€ã«ã®å Žåã®å¯Ÿå¿ååç©ãåŸ
ãŠã (c) çæç©ãå¡©ãšããŠåŸãããæã¯ãä»»æã«ç¡æ©
å¡©åºãšã®åå¿ã«ãã€ãŠéé¢ã¢ãã³ãåŸãã 以äžã®æé ãããªã åŒ K0660 ãåŒäžïŒ²ã¯æ°ŽçŽ ãççŽ ååïŒãïŒåã®äœçŽã¢ã«ã
ã«ãççŽ ååïŒãïŒåã®äœçŽã¢ã«ã«ãã€ã«åã¯ã
ã³ãŸã€ã«ã§ãããR1ãR2ãããY1ã¯äžã«å®
矩ããããšãããã®ååç©ãåã¯è¬åŠçã«åå ¥ã
ããããã®é žä»å å¡©é¡ã®è£œæ³ã
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/260,447 US4329470A (en) | 1981-05-04 | 1981-05-04 | 5-(4-Phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57185280A JPS57185280A (en) | 1982-11-15 |
JPH0261474B2 true JPH0261474B2 (ja) | 1990-12-20 |
Family
ID=22989202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57071660A Granted JPS57185280A (en) | 1981-05-04 | 1982-04-30 | 5-(4-phenyl-1-piperidinyl)methyl-2,3-dihydro- 2-oxo-1h-imidazole-4-carboxylic acid derivatives |
Country Status (10)
Country | Link |
---|---|
US (1) | US4329470A (ja) |
EP (1) | EP0064706B1 (ja) |
JP (1) | JPS57185280A (ja) |
AT (1) | ATE14125T1 (ja) |
AU (1) | AU546961B2 (ja) |
CA (1) | CA1167850A (ja) |
DE (1) | DE3264545D1 (ja) |
ES (1) | ES511871A0 (ja) |
IL (1) | IL65664A (ja) |
ZA (1) | ZA822988B (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5159083A (en) * | 1990-12-28 | 1992-10-27 | Neurogen Corporation | Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands |
US5850564A (en) * | 1995-05-03 | 1998-12-15 | Btr, Inc, | Scalable multiple level tab oriented interconnect architecture |
AU6013998A (en) * | 1996-12-30 | 1998-07-31 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6093737A (en) * | 1996-12-30 | 2000-07-25 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6127390A (en) * | 1997-10-02 | 2000-10-03 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2441933A (en) * | 1945-07-30 | 1948-05-18 | Hoffmann La Roche | Substituted imidazolones and process of making them |
US2441936A (en) * | 1946-03-22 | 1948-05-18 | Hoffmann La Roche | Imidazolones and method of preparation |
US2514380A (en) * | 1946-12-26 | 1950-07-11 | Hoffmann La Roche | Diamines and method of production |
US3303199A (en) * | 1963-07-15 | 1967-02-07 | Geigy Chem Corp | Certain imidazolone derivatives and process for making same |
NZ193935A (en) * | 1979-06-18 | 1985-05-31 | Richardson Merrell Inc | 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions |
-
1981
- 1981-05-04 US US06/260,447 patent/US4329470A/en not_active Expired - Lifetime
-
1982
- 1982-04-30 AU AU83177/82A patent/AU546961B2/en not_active Ceased
- 1982-04-30 JP JP57071660A patent/JPS57185280A/ja active Granted
- 1982-04-30 CA CA000402069A patent/CA1167850A/en not_active Expired
- 1982-04-30 ZA ZA822988A patent/ZA822988B/xx unknown
- 1982-05-02 IL IL65664A patent/IL65664A/xx not_active IP Right Cessation
- 1982-05-03 EP EP82103742A patent/EP0064706B1/en not_active Expired
- 1982-05-03 DE DE8282103742T patent/DE3264545D1/de not_active Expired
- 1982-05-03 AT AT82103742T patent/ATE14125T1/de not_active IP Right Cessation
- 1982-05-03 ES ES511871A patent/ES511871A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS57185280A (en) | 1982-11-15 |
ES8308870A1 (es) | 1983-10-01 |
US4329470A (en) | 1982-05-11 |
DE3264545D1 (en) | 1985-08-08 |
ES511871A0 (es) | 1983-10-01 |
AU8317782A (en) | 1982-11-11 |
IL65664A0 (en) | 1982-08-31 |
ZA822988B (en) | 1983-03-30 |
EP0064706B1 (en) | 1985-07-03 |
IL65664A (en) | 1986-01-31 |
ATE14125T1 (de) | 1985-07-15 |
AU546961B2 (en) | 1985-09-26 |
CA1167850A (en) | 1984-05-22 |
EP0064706A1 (en) | 1982-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1277894A3 (ru) | СпПÑПб пПлÑÑеМО 3-/1-ОЌОЎазПлОлалкОл/ОМЎПлПв ОлО ÐžÑ ÑаÑЌаÑевÑОÑеÑкО пÑОеЌлеЌÑÑ ÐºÐžÑлПÑМП-аЎЎОÑОвМÑÑ ÑПлей | |
JP2972377B2 (ja) | ã«ãã³ãŒã«èªå°äœããã®è¬åŠçã«èš±å®¹ãããå¡©ããã³ãšã¹ãã«ãªãã³ã«ããããå«æããå»è¬çµæç© | |
JPH072851A (ja) | ïŒå¡è€çŽ ç°ååç©ããããã®èª¿è£œæ¹æ³åã³ãããã®ååç©ãå«ãå»è¬çµæç© | |
PL168311B1 (pl) | Sposób wytwarzania terapeutycznie czynnych zwiazków imidazolowych PL | |
HU184797B (en) | Process for preparing quinazoline derivatives | |
IE49231B1 (en) | 3,4-dichlorobenzyl alcohol derivatives | |
JPH0261474B2 (ja) | ||
US4371737A (en) | 5-Aminomethyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives | |
HU193918B (en) | Process for preparing dihydropyridine derivatives | |
JP2948076B2 (ja) | æ°èŠãã¢ãŸãªãžã³ãžãªã³ååç© | |
EP0064704B1 (en) | 4-aminomethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones | |
US4329471A (en) | 4-(4-Phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones | |
HU192634B (en) | Pharmaceutical compositions containing process for preparing 4-aroyl-imidazol-2-one derivatives | |
EP0495226B1 (en) | 3-Aryl-5-alkylthio-4H-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma | |
IE53188B1 (en) | 4-piperidinomethyl-1,3-dihydro-2h-imidazole-2-ones | |
JPS5976083A (ja) | ãžãããããªãžã³é¡ | |
US4526981A (en) | [1,2-Dihydro-4(5)-acyl-2-oxo-2H-imidazol-4(5)-yl] methyl nitrates | |
EP0065165B1 (en) | 5-oxymethyl-4-acyl-1,3-dihydro-2h-imidazol-2-ones | |
DK160821B (da) | 1,3-dihydro-4-benzoyl-2h-imidazol-2-oner samt middel til behandling af hjertesvigt | |
JPH02193978A (ja) | ããŒããã³âβâããããã·ã©ãŒãŒæå¶å€ | |
JPH0465810B2 (ja) | ||
IE53316B1 (en) | 4-aminomethyl-1,3-dihydro-2h-imidazol-2-ones | |
US4234594A (en) | Pyrazolyl amino imidazolines as antihypertensive agents | |
RU2096407C1 (ru) | ÐÑПОзвПЎМÑе каÑÐµÑ ÐŸÐ»Ð° О ÑпПÑПб ÐžÑ Ð¿ÐŸÐ»ÑÑÐµÐœÐžÑ | |
JPH0435466B2 (ja) |